[10-Q] SYNCHRONOSS TECHNOLOGIES INC Quarterly Earnings Report

Rhea-AI Filing Summary

Synchronoss Technologies reported Q3 2025 results with net revenues of $42,003 thousand and income from operations of $5,869 thousand. Net income was $5,813 thousand (diluted EPS $0.51), compared with a loss a year ago, as lower operating costs and higher interest income offset interest expense.

For the nine months, revenue was $126,702 thousand and net loss was $17,608 thousand. Cash from operating activities was $41,936 thousand, aided by a $28,627 thousand federal tax return receipt. The company received a $33.9 million CARES Act tax refund and used $25.4 million to prepay its 2025 Term Loan. Cash and cash equivalents were $34,827 thousand and long‑term debt (carrying value) was $163,200 thousand.

Subscription Services remained the core driver (Q3: $39,389 thousand), with North America contributing $40,430 thousand. Stockholders’ equity rose to $55,354 thousand, reflecting comprehensive income and the removal of a $12,500 thousand redeemable non‑controlling interest. As of November 3, 2025, 11,507,434 common shares were outstanding.

Insights

Equity analyst – software & fintech

Q3 swung to profit; leverage remains the key variable.

Synchronoss delivered Q3 net revenue of $42,003 thousand and net income of $5,813 thousand, a clear turnaround from last year’s loss. Operating costs declined year over year, and interest income of $5,404 thousand supported results despite interest expense of $7,776 thousand.

Year to date, revenue is $126,702 thousand with a net loss of $17,608 thousand, reflecting earlier non‑operational items including debt‑related charges and foreign exchange. The business remains anchored by Subscription Services, which provided $39,389 thousand in Q3.

Liquidity improved: operating cash flow was $41,936 thousand, and a $33.9 million CARES Act refund drove a $25.4 million prepayment on the 2025 Term Loan, reducing required principal through approximately January 2028. The filing states covenant compliance; future performance will hinge on sustaining subscription revenue and managing interest costs.

0001131554FALSEDecember 312025Q3http://synchronoss.com/20250930#HanoverRateMemberhttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrenthttp://synchronoss.com/20250930#LeaseLiabilityNoncurrenthttp://synchronoss.com/20250930#LeaseLiabilityNoncurrenthttp://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember33.3333.3333.3333.3333.3333.33xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puresncr:segmentsncr:notesncr:votesncr:compensation_plan00011315542025-01-012025-09-3000011315542025-11-0300011315542025-09-3000011315542024-12-3100011315542025-07-012025-09-3000011315542024-07-012024-09-3000011315542024-01-012024-09-300001131554us-gaap:CommonStockMember2025-06-300001131554us-gaap:AdditionalPaidInCapitalMember2025-06-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001131554us-gaap:RetainedEarningsMember2025-06-3000011315542025-06-300001131554us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001131554us-gaap:CommonStockMember2025-07-012025-09-300001131554us-gaap:RetainedEarningsMember2025-07-012025-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001131554us-gaap:CommonStockMember2025-09-300001131554us-gaap:AdditionalPaidInCapitalMember2025-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001131554us-gaap:RetainedEarningsMember2025-09-300001131554us-gaap:CommonStockMember2024-06-300001131554us-gaap:AdditionalPaidInCapitalMember2024-06-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001131554us-gaap:RetainedEarningsMember2024-06-3000011315542024-06-300001131554us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001131554us-gaap:CommonStockMember2024-07-012024-09-300001131554us-gaap:RetainedEarningsMember2024-07-012024-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001131554us-gaap:CommonStockMember2024-09-300001131554us-gaap:AdditionalPaidInCapitalMember2024-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001131554us-gaap:RetainedEarningsMember2024-09-3000011315542024-09-300001131554us-gaap:CommonStockMember2024-12-310001131554us-gaap:AdditionalPaidInCapitalMember2024-12-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001131554us-gaap:RetainedEarningsMember2024-12-310001131554us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001131554us-gaap:CommonStockMember2025-01-012025-09-300001131554us-gaap:RetainedEarningsMember2025-01-012025-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001131554us-gaap:CommonStockMember2023-12-310001131554us-gaap:AdditionalPaidInCapitalMember2023-12-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001131554us-gaap:RetainedEarningsMember2023-12-3100011315542023-12-310001131554us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001131554us-gaap:CommonStockMember2024-01-012024-09-300001131554us-gaap:RetainedEarningsMember2024-01-012024-09-300001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001131554us-gaap:LongTermDebtMember2025-01-012025-09-300001131554us-gaap:LongTermDebtMember2024-01-012024-09-300001131554us-gaap:SeniorNotesMember2025-01-012025-09-300001131554us-gaap:SeniorNotesMember2024-01-012024-09-300001131554srt:NorthAmericaMember2025-07-012025-09-300001131554srt:NorthAmericaMember2024-07-012024-09-300001131554srt:NorthAmericaMember2025-01-012025-09-300001131554srt:NorthAmericaMember2024-01-012024-09-300001131554srt:AsiaPacificMember2025-07-012025-09-300001131554srt:AsiaPacificMember2024-07-012024-09-300001131554srt:AsiaPacificMember2025-01-012025-09-300001131554srt:AsiaPacificMember2024-01-012024-09-300001131554us-gaap:EMEAMember2025-07-012025-09-300001131554us-gaap:EMEAMember2024-07-012024-09-300001131554us-gaap:EMEAMember2025-01-012025-09-300001131554us-gaap:EMEAMember2024-01-012024-09-300001131554sncr:ProfessionalServicesMember2025-07-012025-09-300001131554sncr:ProfessionalServicesMember2024-07-012024-09-300001131554sncr:ProfessionalServicesMember2025-01-012025-09-300001131554sncr:ProfessionalServicesMember2024-01-012024-09-300001131554sncr:SubscriptionServicesMember2025-07-012025-09-300001131554sncr:SubscriptionServicesMember2024-07-012024-09-300001131554sncr:SubscriptionServicesMember2025-01-012025-09-300001131554sncr:SubscriptionServicesMember2024-01-012024-09-300001131554us-gaap:LicenseMember2025-07-012025-09-300001131554us-gaap:LicenseMember2024-07-012024-09-300001131554us-gaap:LicenseMember2025-01-012025-09-300001131554us-gaap:LicenseMember2024-01-012024-09-3000011315542025-07-012025-09-300001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2025-07-012025-09-300001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2024-07-012024-09-300001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2025-01-012025-09-300001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2024-01-012024-09-300001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2025-07-012025-09-300001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2024-07-012024-09-300001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2025-01-012025-09-300001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2024-01-012024-09-300001131554sncr:ReportableSegmentMember2025-07-012025-09-300001131554sncr:ReportableSegmentMember2024-07-012024-09-300001131554sncr:ReportableSegmentMember2025-01-012025-09-300001131554sncr:ReportableSegmentMember2024-01-012024-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMember2022-06-230001131554sncr:AccountsReceivableSecuritizationFacilityMember2022-06-232022-06-230001131554sncr:AccountsReceivableSecuritizationFacilityMember2025-07-012025-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMember2024-07-012024-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMember2025-01-012025-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMember2024-01-012024-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMembersncr:SNTechnologiesMember2025-09-300001131554sncr:AccountsReceivableSecuritizationFacilityMember2025-09-300001131554us-gaap:FairValueInputsLevel1Member2025-09-300001131554us-gaap:FairValueInputsLevel2Member2025-09-300001131554us-gaap:FairValueInputsLevel3Member2025-09-300001131554us-gaap:FairValueInputsLevel1Member2024-12-310001131554us-gaap:FairValueInputsLevel2Member2024-12-310001131554us-gaap:FairValueInputsLevel3Member2024-12-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMemberus-gaap:LoansPayableMember2020-06-300001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMember2022-12-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMembersncr:PromissoryNoteMember2024-03-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMembersncr:PromissoryNoteMember2025-01-082025-01-080001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-240001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-01-012025-09-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-05-122025-05-120001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-04-242025-04-240001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-04-240001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-01-012025-09-300001131554sncr:A2025TermLoanMemberus-gaap:SeniorNotesMember2025-04-242025-04-240001131554sncr:A2025TermLoanMembersrt:MinimumMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:A2025TermLoanMembersrt:MaximumMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:PeriodOneMembersncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:PeriodTwoMembersncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:PeriodThreeMembersncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:PeriodFourMembersncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-04-242025-04-240001131554sncr:A2020CARESActMember2025-07-310001131554sncr:A2020CARESActMember2025-07-012025-07-310001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-07-012025-07-310001131554sncr:TermLoanMember2025-07-012025-07-310001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2025-09-300001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-06-280001131554sncr:A2021SeniorNotesMember2024-06-282024-06-280001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2024-06-280001131554sncr:A2021SeniorNotesMember2024-06-280001131554us-gaap:SeriesBPreferredStockMember2024-06-282024-06-280001131554us-gaap:SeriesBPreferredStockMember2024-06-280001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-06-282024-06-280001131554sncr:A2024TermLoanMember2025-01-012025-09-300001131554sncr:A2024TermLoanMember2024-01-012024-09-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2021-06-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2021-06-302021-06-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2021-10-250001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2021-10-252021-10-250001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2021-12-3100011315542024-06-282024-06-280001131554sncr:BRPIMemberus-gaap:SeniorNotesMember2024-06-280001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2024-06-282024-06-280001131554sncr:A2025TermLoanMemberus-gaap:SeniorNotesMember2025-05-122025-05-120001131554sncr:A2025TermLoanMemberus-gaap:SeniorNotesMember2025-05-120001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-09-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2024-12-310001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2025-09-300001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-12-310001131554sncr:A2025TermLoanMemberus-gaap:LineOfCreditMember2024-12-310001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2025-07-012025-09-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2024-07-012024-09-300001131554sncr:A2021SeniorNotesMemberus-gaap:SeniorNotesMember2024-01-012024-09-300001131554sncr:A2024TermLoanMember2025-07-012025-09-300001131554sncr:A2024TermLoanMember2024-07-012024-09-300001131554sncr:A2025TermLoanMember2025-07-012025-09-300001131554sncr:A2025TermLoanMember2024-07-012024-09-300001131554sncr:A2025TermLoanMember2025-01-012025-09-300001131554sncr:A2025TermLoanMember2024-01-012024-09-300001131554us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001131554us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300001131554us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsAttributableToParentMember2024-12-310001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsAttributableToParentMember2025-01-012025-09-300001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsAttributableToParentMember2025-09-300001131554us-gaap:PreferredStockMember2025-09-300001131554us-gaap:CommonStockMember2025-01-012025-09-300001131554us-gaap:SeriesBPreferredStockMemberus-gaap:PrivatePlacementMember2021-06-302021-06-300001131554us-gaap:SeriesBPreferredStockMember2021-06-300001131554us-gaap:SeriesBPreferredStockMember2025-09-300001131554sncr:ZentryMemberus-gaap:RelatedPartyMember2015-12-1500011315542015-12-312015-12-3100011315542025-04-012025-06-300001131554sncr:EquityIncentivePlan2015Member2025-09-300001131554sncr:NewHireEquityIncentivePlan2017Member2025-09-300001131554sncr:PerformanceBasedCashUnitsMember2025-01-012025-09-300001131554sncr:PerformanceBasedCashUnitsMember2025-09-300001131554sncr:EquityIncentivePlan2015Membersncr:PerformanceBasedCashUnitsMember2025-09-300001131554us-gaap:CostOfSalesMember2025-07-012025-09-300001131554us-gaap:CostOfSalesMember2024-07-012024-09-300001131554us-gaap:CostOfSalesMember2025-01-012025-09-300001131554us-gaap:CostOfSalesMember2024-01-012024-09-300001131554us-gaap:ResearchAndDevelopmentExpenseMember2025-07-012025-09-300001131554us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001131554us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-09-300001131554us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-09-300001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-07-012025-09-300001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-09-300001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300001131554sncr:EmployeeAndDirectorsStockOptionsMember2025-07-012025-09-300001131554sncr:EmployeeAndDirectorsStockOptionsMember2024-07-012024-09-300001131554sncr:EmployeeAndDirectorsStockOptionsMember2025-01-012025-09-300001131554sncr:EmployeeAndDirectorsStockOptionsMember2024-01-012024-09-300001131554us-gaap:RestrictedStockMember2025-07-012025-09-300001131554us-gaap:RestrictedStockMember2024-07-012024-09-300001131554us-gaap:RestrictedStockMember2025-01-012025-09-300001131554us-gaap:RestrictedStockMember2024-01-012024-09-300001131554us-gaap:PerformanceSharesMember2025-07-012025-09-300001131554us-gaap:PerformanceSharesMember2024-07-012024-09-300001131554us-gaap:PerformanceSharesMember2025-01-012025-09-300001131554us-gaap:PerformanceSharesMember2024-01-012024-09-300001131554us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2025-01-012025-09-300001131554us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-01-012025-09-300001131554us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-09-300001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-09-300001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2025-01-012025-09-300001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-01-012025-09-300001131554us-gaap:EmployeeSeveranceMember2024-12-310001131554us-gaap:EmployeeSeveranceMember2025-01-012025-09-300001131554us-gaap:EmployeeSeveranceMember2025-09-300001131554sncr:OptionsAndUnvestedRestrictedSharesMember2025-07-012025-09-300001131554sncr:OptionsAndUnvestedRestrictedSharesMember2024-07-012024-09-300001131554sncr:OptionsAndUnvestedRestrictedSharesMember2025-01-012025-09-300001131554sncr:OptionsAndUnvestedRestrictedSharesMember2024-01-012024-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from          to

Commission file number 001-40574

SYNCHRONOSS TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware			06-1594540
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
200 Crossing Boulevard, 8th Floor Bridgewater, New Jersey			08807
(Address of principal executive offices)			(Zip Code)

(866) 620-3940

(Registrant’s telephone number, including area code) 

(Former name, former address, and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

☐

Accelerated filer

x

Non-accelerated filer

☐

Smaller Reporting Company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.0001 par value

SNCR

The Nasdaq Stock Market, LLC

As of November 3, 2025, there were 11,507,434 shares of common stock issued and outstanding.

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

FORM 10-Q INDEX

						Page No.
PART I.			FINANCIAL INFORMATION			3
Item 1.			Condensed Consolidated Financial Statements and Notes			3
			Condensed Consolidated Balance Sheets (unaudited)			3
			Condensed Consolidated Statements of Operations (unaudited)			4
			Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)			5
			Condensed Consolidated Statements of Stockholders’ Equity (unaudited)			6
			Condensed Consolidated Statements of Cash Flows (unaudited)			8
			Notes to Condensed Consolidated Financial Statements (unaudited)			10
			Note 1. Description of Business			10
			Note 2. Basis of Presentation and Consolidation			10
			Note 3. Revenue			12
			Note 4. Segments			14
			Note 5. Accounts Receivable Securitization Facility			15
			Note 6. Fair Value Measurements			16
			Note 7. Note Receivable			16
			Note 8. Leases			17
			Note 9. Debt			20
			Note 10. Accumulated Other Comprehensive Loss			25
			Note 11. Capital Structure			26
			Note 12. Restructuring			30
			Note 13. Income Taxes			30
			Note 14. Earnings Per Common Share			31
			Note 15. Commitments			32
			Note 16. Legal Matters			33
Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations			34
Item 3.			Quantitative and Qualitative Disclosures About Market Risk			41
Item 4.			Controls and Procedures			42
PART II.			OTHER INFORMATION			44
Item 1.			Legal Proceedings			44
Item 1A.			Risk Factors			44
Item 2.			Unregistered Sales of Equity Securities and Use of Proceeds			44
Item 3.			Defaults Upon Senior Securities			45
Item 4.			Mine Safety Disclosures			45
Item 5.			Other Information			45
Item 6.			Exhibits			46
SIGNATURES						47

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited) (In thousands)

						September 30, 2025						December 31, 2024
ASSETS
Current assets:
Cash and cash equivalents						$	34,827					$	33,375
Accounts receivable, net						17,508						18,129
Prepaid & other current assets						8,684						29,878
Total current assets						61,019						81,382
Non-current assets:
Property and equipment, net						3,891						3,154
Operating lease right-of-use assets						3,520						8,445
Goodwill						188,784						179,408
Intangible assets, net						18,862						19,117
Other assets, non-current						2,144						2,319
Total non-current assets						217,201						212,443
Total assets						$	278,220					$	293,825
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable						$	5,383					$	7,067
Accrued expenses						34,341						30,519
Deferred revenues, current						100						837
Debt, current						—						1,875
Total current liabilities						39,824						40,298
Long-term debt, net of debt issuance costs						163,200						184,840
Deferred tax liabilities						3,320						4,903
Leases, non-current						10,141						16,776
Other liabilities, non-current						6,381						4,733
Total liabilities						222,866						251,550
Commitments and contingencies:
Redeemable non-controlling interest						—						12,500
Stockholders’ equity:
Common stock, $0.0001 par value; 16,667 and 16,667 shares authorized, 11,507 and 11,075 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively						1						1
Additional paid-in capital						511,125						495,906
Accumulated other comprehensive loss						(13,169)						(41,137)
Accumulated deficit						(442,603)						(424,995)
Total stockholders’ equity						55,354						29,775
Total liabilities and stockholders’ equity						$	278,220					$	293,825

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited) (In thousands, except per share data)

						Three Months Ended September 30,																		Nine Months Ended September 30,
						2025						2024												2025						2024
Net revenues						$	42,003					$	42,964											$	126,702					$	129,387
Costs and expenses:
Cost of revenues1						8,665						8,975												26,298						29,599
Research and development						10,837						10,333												30,939						32,560
Selling, general and administrative						12,174						13,755												35,404						39,800
Restructuring charges						—						—												165						267
Depreciation and amortization						4,458						4,386												12,938						12,773
Total costs and expenses						36,134						37,449												105,744						114,999
Income from operations						5,869						5,515												20,958						14,388
Interest income						5,404						165												5,906						556
Interest expense						(7,776)						(5,526)												(19,763)						(12,529)
Debt modification expense						—						—												(4,384)						—
Loss on debt extinguishment						—						—												(1,993)						—
Foreign exchange gain (loss)						512						(5,461)												(17,598)						(440)
Other income, net						8						220												11						230
Income (loss) from operations, before taxes						4,017						(5,087)												(16,863)						2,205
Benefit (provision) for income taxes						1,796						(628)												(745)						(3,939)
Net income (loss)						5,813						(5,715)												(17,608)						(1,734)
Net income attributable to redeemable non-controlling interests						—						14												—						14
Preferred stock dividend, net of gain on repurchase of preferred stock						—						—												—						(1,562)
Net income (loss) attributable to Synchronoss						$	5,813					$	(5,701)											$	(17,608)					$	(3,282)
Earnings (loss) per share:
Basic						$	0.55					$	(0.56)											$	(1.70)					$	(0.33)
Diluted						$	0.51					$	(0.56)											$	(1.70)					$	(0.33)
Weighted average common shares outstanding:
Basic						10,632						10,095												10,357						9,994
Diluted						11,473						10,095												10,357						9,994

________________________________

1    Cost of revenues excludes depreciation and amortization which are shown separately.

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited) (In thousands)

						Three Months Ended September 30,																		Nine Months Ended September 30,
						2025						2024												2025						2024
Net income (loss)						$	5,813					$	(5,715)											$	(17,608)					$	(1,734)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments						(868)						9,279												27,968						1,004
Comprehensive income (loss)						4,945						3,564												10,360						(730)
Comprehensive income attributable to redeemable non-controlling interests						—						14												—						14
Comprehensive income (loss) attributable to Synchronoss						$	4,945					$	3,578											$	10,360					$	(716)

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited) (In thousands)

			Three Months Ended September 30, 2025
			Common Stock
			Shares						Par Value																		Additional Paid-In Capital						Accumulated Other Comprehensive (Loss) Income						Accumulated Deficit						Total Stockholders' Equity
Balance at June 30, 2025			11,497						$	1																	$	510,149					$	(12,301)					$	(448,416)					$	49,433
Stock-based compensation			—						—																		976						—						—						976
Issuance of restricted stock, net			10						—																		—						—						—						—
Net income			—						—																		—						—						5,813						5,813
Total other comprehensive loss			—						—																		—						(868)						—						(868)
Balance at September 30, 2025			11,507						$	1																	$	511,125					$	(13,169)					$	(442,603)					$	55,354

			Three Months Ended September 30, 2024
			Common Stock
			Shares						Par Value																		Additional Paid-In Capital						Accumulated Other Comprehensive (Loss) Income						Accumulated Deficit						Total Stockholders' Equity
Balance at June 30, 2024			10,815						$	1																	$	491,808					$	(34,007)					$	(427,183)					$	30,619
Stock-based compensation			—						—																		884						—						—						884
Issuance of common stock on exercise of options			22						—																		236						—						—						236
Issuance of restricted stock			2						—																		—						—						—						—
Net loss			—						—																		—						—						(5,715)						(5,715)
Non-controlling interest			—						—																		(14)						—						14						—
Total other comprehensive income			—						—																		—						9,279						—						9,279
Balance at September 30, 2024			10,839						$	1																	$	492,914					$	(24,728)					$	(432,884)					$	35,303

See accompanying notes to condensed consolidated financial statements.

6

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited) (In thousands) (Continued)

			Nine Months Ended September 30, 2025
			Common Stock
			Shares						Par Value																		Additional Paid-In Capital						Accumulated Other Comprehensive (Loss) Income						Accumulated deficit						Total Stockholders' Equity
Balance at December 31, 2024			11,075						$	1																	$	495,906					$	(41,137)					$	(424,995)					$	29,775
Stock-based compensation			—						—																		3,528						—						—						3,528
Issuance of restricted stock, net			510						—																		—						—						—						—
Issuance of common stock on exercise of options			1						—																		13						—						—						13
Shares withheld for taxes in connection with issuance of restricted stock			(79)						—																		(822)						—						—						(822)
Net loss			—						—																		—						—						(17,608)						(17,608)
Total other comprehensive income			—						—																		—						27,968						—						27,968
Zentry partnership termination1			—						—																		12,500						—						—						12,500
Balance at September 30, 2025			11,507						$	1																	$	511,125					$	(13,169)					$	(442,603)					$	55,354

________________________________

1    For further detail on Zentry partnership termination refer to Note 11. Capital Structure of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.

			Nine Months Ended September 30, 2024
			Common Stock
			Shares						Par Value																		Additional Paid-In Capital						Accumulated Other Comprehensive (Loss) Income						Accumulated deficit						Total Stockholders' Equity
Balance at December 31, 2023			10,314						$	1																	$	483,527					$	(25,732)					$	(431,164)					$	26,632
Stock-based compensation			—						—																		2,866						—						—						2,866
Issuance of common stock on exercise of options			22						—																		236						—						—						236
Shares withheld for taxes in connection with issuance of restricted stock			—						—																		(1)						—						—						(1)
Issuance of restricted stock			503						—																		—						—						—						—
Preferred stock dividend			—						—																		(4,258)						—						—						(4,258)
Net loss			—						—																		—						—						(1,734)						(1,734)
Non-controlling interest			—						—																		(14)						—						14						—
Total other comprehensive income			—						—																		—						1,004						—						1,004
Gain on Senior Notes repurchase			—						—																		7,862						—						—						7,862
Gain on Series B Preferred stock redemption			—						—																		2,696						—						—						2,696
Balance at September 30, 2024			10,839						$	1																	$	492,914					$	(24,728)					$	(432,884)					$	35,303

See accompanying notes to condensed consolidated financial statements.

7

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited) (In thousands)

						Nine Months Ended September 30,
						2025						2024
Operating activities:
Net loss						$	(17,608)					$	(1,734)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization						12,938						12,773
Amortization of debt issuance costs and debt discount						3,969						1,570
Loss on debt extinguishment						1,993						—
Sublease receivable impairment						—						806
Deferred income taxes						(1,724)						710
Stock-based compensation						4,292						5,376
Operating lease impairment, net						627						2,163
Other, net						(5)						(205)
Non-cash foreign currency impact						16,756						257
Changes in operating assets and liabilities:
Accounts receivable, net						849						3,386
Prepaid expenses and other current assets						(4,336)						(1,098)
Other current assets (federal tax return receipt)						28,627						—
Accounts payable						(3,057)						(1,527)
Accrued expenses						3,640						(6,717)
Other assets, non-current						240						290
Deferred revenues						(824)						407
Other liabilities						(4,441)						(1,252)
Net cash provided by operating activities						$	41,936					$	15,205

See accompanying notes to condensed consolidated financial statements. 

8

Table of Contents

SYNCHRONOSS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited) (In thousands) (Continued)

						Nine Months Ended September 30,
						2025						2024
Investing activities:
Purchases of fixed assets						$	(1,013)					$	(1,038)
Additions to capitalized software						(9,170)						(9,864)
Proceeds from the sale of intangibles						—						278
Proceeds from the divestiture, net						—						1,515
Net cash used in investing activities						(10,183)						(9,109)
Financing activities:
Share-based compensation-related proceeds						13						236
Taxes paid on withholding shares						(822)						(1)
Cash proceeds from issuance of long-term debt						126,406						75,000
Debt issuance costs related to long-term debt						(7,896)						(6,792)
Repayment of long-term debt						(25,870)						(469)
Retirement of Senior Notes						(121,387)						(11,524)
Debt extinguishment costs related to Senior Notes						(729)						—
Drawdown on A/R Facility						6,000						9,000
Repayment of A/R Facility						(6,000)						(9,000)
Series B Preferred dividend paid in the form of cash						—						(4,258)
Redemption of Series B Preferred stock						—						(57,576)
Net cash used in financing activities						(30,285)						(5,384)
Effect of exchange rate changes on cash						(16)						(56)
Net increase in cash and cash equivalents						1,452						656
Beginning cash and cash equivalents						33,375						24,572
Ending cash and cash equivalents						$	34,827					$	25,228

See accompanying notes to condensed consolidated financial statements. 

9

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 1. Description of Business

General

Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) is a leading provider of white label cloud software and services that enable our customers to keep subscribers, systems, networks, and content in sync.

The Synchronoss Personal CloudTM platform is a secure and highly scalable white label platform that allows our customers’ subscribers to backup and protect, engage with, and manage their personal content and gives our operator customers the ability to increase average revenue per user (“ARPU”) and reduce churn.

Designed for smartphones, tablets, and desktops across all operating systems, our platform ensures a seamless cross-device experience.

Note 2. Basis of Presentation and Consolidation

The accompanying interim unaudited condensed consolidated financial statements have been prepared by Synchronoss and, in the opinion of management, include all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, and cash flows for the interim periods. They do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements and should be read in conjunction with the Company’s audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025.

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany transactions and accounts are eliminated in consolidation.

Unless otherwise noted, tables are presented in U.S. dollars in thousands. Certain columns and rows may not add due to the use of rounded numbers. Percentages and Earnings per share (“EPS”) amounts presented are calculated from the underlying numbers in thousands. We may reclassify certain prior year amounts to conform with current year presentation.

For further information about the Company’s basis of presentation and consolidation or its significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Recently Issued Accounting Standards

Standards recently adopted

Standard

Description

Effect on the financial statements

Update 2024-01 - Compensation—Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards

The amendments in this Update related to the scope application issue apply to all reporting entities that account for profits interest awards as compensation to employees or nonemployees in return for goods or services. This Update provides specific examples to help stakeholders to determine whether a profits interest award should be accounted for as a share-based payment arrangement (Topic 718) or similar to a cash bonus or profit-sharing arrangement (Topic 710, Compensation—General, or other Topics).

The Company evaluated these changes and noted that the adoption of this standard did not have a material impact on the Company’s consolidated financial position or results of operations.

Date of adoption: January 1, 2025

10

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Standards issued not yet adopted

Standard

Description

Effect on the financial statements

Update 2025-05 - Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

This Update is to address challenges encountered when applying the guidance in Topic 326, Financial Instruments - Credit Losses, to current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers. The amendments in this Update introduce a practical expedient for all entities and an accounting policy election for entities other than public business entities related to applying Subtopic 326-20 to current AR and current contracts assets arising from transactions under Topic 606.

The Company continues to evaluate these changes and does not anticipate any material impact on the Company’s consolidated financial position or results of operations upon adoption.

Planned date of adoption: January 1, 2026

Update 2025-06 - Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software

The amendments in this Update improve the operability of the guidance for accounting for software costs under Subtopic 350-40 through removing all references to software development stages.

The Company continues to evaluate these changes which may have a material impact on the Company’s consolidated financial position or results of operations upon adoption.

Planned date of adoption: January 1, 2028

Update 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses

Requires a public business entity to disclose, on an annual basis and interim basis, disaggregated information about certain income statement line items in a tabular format in the notes to the financial statements. The guidance does not change what is presented on the face of the income statement.

The Company continues to evaluate these changes and does not anticipate any material impact on the Company’s consolidated financial position or results of operations upon adoption.

Planned date of adoption: January 1, 2027

11

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Update 2023-09 - Income Taxes (Topic 740) - Improvements to Income Tax Disclosures

The amendments in this Update related to the rate reconciliation and income taxes paid disclosures improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction.

The Company evaluated these changes and noted that the adoption of this standard did not have a material impact on the Company’s consolidated financial position or results of operations. The ASU is effective for annual periods beginning after December 15, 2024, and will not impact interim disclosures for 2025. The Company will include additional income tax disclosures in its Annual Report on Form 10-K for the year ending December 31, 2025, as required by ASU Update 2023-09.

Planned date of adoption: December 31, 2025

Note 3. Revenue

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into the nature of the services and geographical regions. The Company’s geographic regions are the North America, Europe, the Middle East and Africa (“EMEA”), and Asia Pacific (“APAC”). The majority of the Company’s revenue is from the technology, media, and telecom (“TMT”) sector.

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
Geography:
North America			$	40,430					$	40,200					$	120,945					$	120,155
APAC			1,236						1,076						4,720						4,229
EMEA			337						1,688						1,037						5,003
Total revenue			$	42,003					$	42,964					$	126,702					$	129,387
Service Line:
Professional Services			$	2,614					$	3,369					$	7,637					$	11,231
Subscription Services			39,389						39,595						118,013						118,058
License			—						—						1,052						98
Total revenue			$	42,003					$	42,964					$	126,702					$	129,387

Trade Accounts Receivable and Contract Balances

The Company classifies its right to consideration in exchange for deliverables as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). For example, the Company recognizes a receivable for revenues related to its time and materials and volume-based contracts. The Company presents such receivables in Trade accounts receivable, net on the Condensed Consolidated Balance Sheets at their net estimated realizable value. The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, and other applicable factors.

12

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. For example, the Company would record a contract asset if it records revenue on a professional services engagement but are not entitled to bill until the Company achieves specified milestones. The Company presents such contract assets in Other current assets and Other noncurrent assets on the Condensed Consolidated Balance Sheets. The contract asset balance was $1.0 million and $0.6 million at September 30, 2025 and December 31, 2024, respectively.

Amounts collected in advance of services being provided are accounted for as contract liabilities, which are presented as Deferred revenue, current on the Condensed Consolidated Balance Sheets and are realized with the associated revenue recognized under the contract. Nearly all of the Company's contract liabilities balance are related to services revenue, primarily subscription services contracts.

The Company’s contract assets and liabilities are reported in a net position on a customer basis at the end of each reporting period.

Significant changes in the contract liabilities balance during the period are as follows:

						Contract Liabilities1
Balance at December 31, 2024						$	837
Amounts billed but not initially recognized as revenue						126,243
Revenue recognized in the period						(126,980)
Balance at September 30, 2025						$	100

________________________________

1    Comprised of Deferred Revenue. $0.7 million of revenue recognized in the period was included in the contract liability balance at the beginning of the period.

Transaction Price Allocated to the Remaining Performance Obligations

Topic 606 requires that the Company disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of September 30, 2025. The Company has elected not to disclose transaction price allocated to remaining performance obligations for:

1.Contracts with an original duration of one year or less, including contracts that can be terminated for convenience without a substantive penalty.

2.Contracts for which the Company recognizes revenues based on the right to invoice for services performed.

3.Variable consideration allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct good or service that forms part of a single performance obligation in accordance with Topic 606 Section 10-25-14(b), for which the criteria in Topic 606 Section 10-32-40 have been met. This applies to a limited number of situations where the Company is dependent upon data from a third party or where fees are highly variable.

Many of the Company’s performance obligations meet one or more of these exemptions. Specifically, the Company has excluded the following from the Company’s remaining performance obligations, all of which will be resolved in the period in which amounts are known:

•consideration for future transactions, above any contractual minimums

•consideration for success-based transactions contingent on third party data

•credits for failure to meet future service level requirements

As of September 30, 2025, the aggregate amount of transaction price allocated to remaining performance obligations, other than those meeting the exclusion criteria above, was $116.9 million, of which approximately 99.6% is expected to be recognized as revenues within 2 years, and the remainder thereafter.

13

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Estimates of revenue expected to be recognized in future periods also exclude unexercised customer options to purchase services that do not represent material rights to the customer. Customer options that do not represent a material right are only accounted for in accordance with Topic 606 when the customer exercises its option to purchase additional goods or services.

Note 4. Segment Information

The Company assessed its current structure and operations and determined it has one operating segment and a single reportable segment as the business is managed and assessed by the chief operating decision-maker based on the consolidated results of the organization. The Chief Executive Officer is the chief operating decision-maker (“CODM”) for the Company.

The segment derives revenues from customers through the Company’s cloud product under software-as-a-service arrangements.

The accounting policies of the single segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net income (loss). The measure of segment assets is reported on the balance sheet as total consolidated assets.

The CODM uses consolidated net income (loss) to evaluate the overall financial performance of the company. The focus is on revenue performance as well as on comparing actual functional spend categories to forecast and, occasionally, prior-year results to assess variances and trends. Decisions regarding resource allocation are primarily made during the annual budget planning process and augmented as needed throughout the year.

Segment operating results and a reconciliation of segment operating income to consolidated net income (loss) are as follows:

						Three Months Ended September 30,												Nine Months Ended September 30,
						2025						2024						2025						2024
Net revenues1						$	42,003					$	42,964					$	126,702					$	129,387
Less (add):
Employees related expense net of capitalized software						20,046						18,247						57,229						57,542
Hosting expense						3,702						3,849						11,203						11,653
Professional services expense						4,082						5,449						13,097						15,178
Other segment items2						3,838						5,298						11,266						17,623
Depreciation and amortization						4,458						4,386						12,938						12,773
Interest income						(5,404)						(165)						(5,906)						(556)
Interest expense						7,776						5,526						19,763						12,529
Debt modification expense						—						—						4,384						—
Loss on debt extinguishment						—						—						1,993						—
Foreign exchange (gain) loss						(512)						5,461						17,598						440
(Benefit) provision for income taxes						(1,796)						628						745						3,939
Segment net income (loss)						$	5,813					$	(5,715)					$	(17,608)					$	(1,734)
Reconciliation of profit or loss
Adjustments and reconciling items						—						—						—						—
Consolidated net income (loss)						$	5,813					$	(5,715)					$	(17,608)					$	(1,734)

_____________________________

1    There are no intra-entity sales or transfers.

2    Other segment items include: administrative expense, facilities expense, maintenance charges, restructuring expense, sales and marketing expense, stock-based compensation expense and other overhead expense.

14

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 5. Accounts Receivable Securitization Facility

On June 23, 2022 (the “A/R Closing Date”), the Company and certain of its subsidiaries (together with the Company, the “Company Group”) entered into a $15 million accounts receivable securitization facility (the “A/R Facility”) with Norddeutsche Landesbank Girozentrale. On June 25, 2025, but effective as of June 17, 2025, the arrangement was amended to extend the expiration date to December 22, 2025, with no other revisions to its terms.

The A/R Facility transaction includes (i) Receivables Purchase Agreements (the “Receivables Purchase Agreements”) dated as of the Closing Date, among the Company, as initial servicer, SN Technologies, LLC, a wholly owned special purpose subsidiary of the Company (“SN Technologies”), as seller, Norddeutsche Landesbank Girozentrale, as administrative agent (the “Administrative Agent”), and the purchasers party thereto, the group agents party thereto and the originators party thereto; (ii) Purchase and Sale Agreements (the “Purchase and Sale Agreements”) dated as of the Closing Date, between the Company Group, as originators (the “Originators”), and SN Technologies, as purchaser; (iii) the Administration Agreement (the “Administration Agreement”) dated as of the Closing Date, between the Company, as servicer, and Finacity Corporation, as administrator; and (iv) the Performance Guaranty (the “Performance Guaranty”) dated as of the Closing Date made by the Company in favor of the Administrative Agent.

Pursuant to the Purchase and Sale Agreements, the Originators will sell existing and future accounts receivable (and related assets) (the “Receivables”) to SN Technologies in exchange for cash and/or subordinated notes. The Originators and SN Technologies intend the transactions contemplated by the Purchase and Sale Agreements to be true sales to SN Technologies by the respective Originators. Pursuant to the Receivables Purchase Agreement, SN Technologies will in turn grant an undivided security interest to the Administrative Agent in the Receivables in exchange for a credit facility permitting borrowings of up to $15 million outstanding from time to time. Yield is payable to the Administrative Agent under the Receivables Purchase Agreements at a variable rate based on the Norddeutsche Landesbank Girozentrale’s Hanover funding rate plus a 2.35% margin. The Company’s commitment fee shall equal 0.85% per annum on the average daily unused outstanding capital. Pursuant to the Performance Guaranty, the Company guarantees the performance of the Originators of their obligations under the Purchase and Sale Agreements.

The Company has not agreed to guarantee any obligations of SN Technologies or the collection of any of the receivables and will not be responsible for any obligations to the extent the failure to perform such obligations by the Company or any Originators results from receivables being uncollectible on account of the insolvency, bankruptcy or lack of creditworthiness or other financial inability to pay of the related obligor.

Unless earlier terminated or subsequently extended pursuant to the terms of the Receivables Purchase Agreement, the A/R Facility will expire on December 22, 2025.

For the three months ended September 30, 2025 the Company drew $3.0 million on the A/R Facility, and had repaid the balance in full as of September 30, 2025. For the three months ended September 30, 2024, the Company drew $3.0 million on the A/R Facility, and had repaid the balance in full as of September 30, 2024. For the nine months ended September 30, 2025 the Company drew $6.0 million on the A/R Facility, and had repaid the balance in full as of September 30, 2025. For the nine months ended September 30, 2024, the Company drew $9.0 million on the A/R Facility, and had repaid the balance in full as of September 30, 2024. The interest associated with the draw and repayment was not material for either period. The drawdown and subsequent repayment of the A/R Facility represent financing activities, as reported on the Condensed Consolidated Statements of Cash Flows. As of September 30, 2025 approximately $3.0 million of the Company’s receivables are held by SN Technologies. As of September 30, 2025 there were no outstanding borrowings against the A/R facility and $1.9 million was available for the Company to draw under the A/R Facility.

15

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 6. Fair Value Measurements

In accordance with US GAAP, fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy prioritizes the inputs used to measure fair value as follows:

•Level 1 - Observable inputs - quoted prices in active markets for identical assets and liabilities.

•Level 2 - Observable inputs other than the quoted prices in active markets for identical assets and liabilities includes quoted prices for similar instruments, quoted prices for identical or similar instruments in inactive markets, and amounts derived from valuation models where all significant inputs are observable in active markets.

•Level 3 - Unobservable inputs - includes amounts derived from valuation models where one or more significant inputs are unobservable and require the Company to develop relevant assumptions.

The following is a summary of assets and liabilities, and their related classifications under the fair value hierarchy:

			September 30, 2025
			Total						(Level 1)						(Level 2)						(Level 3)
Assets
Money market accounts1			$	18,164					$	18,164					$	—					$	—
Total assets			$	18,164					$	18,164					$	—					$	—
Liabilities
Performance-based cash units2,3			$	1,714					$	—					$	1,714					$	—
Total liabilities			$	1,714					$	—					$	1,714					$	—

			December 31, 2024
			Total						(Level 1)						(Level 2)						(Level 3)
Assets
Money market accounts1			$	9,552					$	9,552					$	—					$	—
Total assets			$	9,552					$	9,552					$	—					$	—
Liabilities
Performance-based cash units2,3			$	948					$	—					$	948					$	—
Total liabilities			$	948					$	—					$	948					$	—

________________________________

1    Included in Cash and cash equivalents on the Condensed Consolidated Balance Sheets.

2    The short-term portion is included in Accrued expenses and the long-term portion is included in Other liabilities, non-current on the Condensed Consolidated Balance Sheets.

3    For a discussion of performance-based cash units see Note 11. Capital Structure of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.

Refer to Note 9. Debt of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q for presentation of Fair Value of Debt.

Note 7. Note Receivable

Sequential Technology International, LLC

During the second quarter of 2020, the Company entered into an agreement with Sequential Technology International, LLC (“STIN”) and AP Capital Holdings II, LLC (“APC”) to divest its remaining equity interest in STIN as well as settle its paid-in-kind purchase money note (“PIK note”) and certain amounts due as of December 31, 2019 in consideration for a $9.0 million secured promissory note (the “Note”). As of December 31, 2022, the carrying value of the Note after the consideration of the allowance for credit loss was approximately $4.8 million. The Company determined the allowance on the Note using a discounted cash flow analysis, which discounts the expected future cash flows of the asset to determine the collectible amount.

16

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

During the third quarter of 2023, the interest payment for the Note was not received by the Company from STIN. In the third quarter of 2023 the Company reassessed the collectability of the Note and determined that a full allowance for credit losses was required equal to the carrying value of the Note, recorded within the Selling, general and administrative expenses line item on the Consolidated Statements of Operations.

During the first quarter of 2024, the Company entered into an agreement with STIN and APC to amend the aforementioned promissory note and reduce the principal balance to $3.0 million, forgive outstanding accrued interest and extend the maturity date of the Note to September 2027.

On January 8, 2025, the Company and STIN, APC and Sequential Technology International Holdings, LLC (collectively the “Sequential Parties”) entered into an Amended and Restated Settlement Agreement (“Settlement Agreement”) to further amend the amounts due from STIN under the Note in connection with a transaction through which the Sequential Parties were acquired. Under the Settlement Agreement the Company received $1.6 million in past-due rent and contingent consideration which the Company may be entitled to if certain key performance indicators are met within the time periods specified in that Agreement. Given the full allowance for credit losses had been recorded against the Note in 2023, the modification of the terms of the Note had no net impact on the consolidated financial statements for the nine months ended September 30, 2025.

Note 8. Leases

The Company has entered into contracts with third parties to lease a variety of assets, including certain real estate, equipment and other assets. The Company’s leases frequently allow for lease payments that could vary based on factors such as inflation or the degree of utilization of the underlying asset. For example, certain of the Company’s real estate leases could require us to make payments that vary based on common area maintenance charges, insurance, and other charges. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company is party to certain sublease arrangements, primarily related to the Company’s real estate leases, where it acts as the lessee and intermediate lessor.

Assets under operating leases are included in Operating lease right-of-use assets, with the related short-term liabilities included in Accrued expenses and long-term portion included in Leases, non-current on the Condensed Consolidated Balance Sheets.

Assets under finance leases are included in Property, plant and equipment, net, with the related short-term liabilities included in Accrued expenses and long-term portion in Leases, non-current on the Condensed Consolidated Balance Sheets.

Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.

17

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

The following table presents information about the Company's right-of-use (“ROU”) assets and lease liabilities:

						September 30, 2025						December 31, 2024
Operating lease assets:
Non-current operating lease ROU assets						$	3,520					$	8,445
Finance lease assets:
Equipment, net						2,002						1,137
Operating lease liabilities:
Lease liabilities, current						6,283						6,010
Lease liabilities, non-current1						9,007						16,320
Total operating lease liabilities						$	15,290					$	22,330
Finance lease liabilities:
Lease liabilities, current						1,113						722
Lease liabilities, non-current						1,134						456
Total finance lease liabilities						$	2,247					$	1,178

________________________________

1    The decrease in operating lease liabilities was primarily due to ordinary lease payments, a $2.4 million related to remeasurement of the Bridgewater, NJ lease and the termination of the first floor Dublin, Ireland lease.

The following table presents information about lease expense and sublease income:

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
Finance leases:
Interest expense			$	68					$	26					$	133					$	77
Depreciation expense			292						164						673						478
Total finance leases			$	360					$	190					$	806					$	555
Operating leases:
Operating lease cost1			$	754					$	1,139					$	2,769					$	3,960
Other lease costs and income:
Variable lease costs1			293						262						1,218						572
ROU assets impairments, net1,2			—						(115)						627						2,163
Sublease income1,3			(334)						(572)						(3,570)						(1,882)
Total operating leases			713						714						1,044						4,813
Total net lease cost			$	1,073					$	904					$	1,850					$	5,368

________________________________

1    Amounts are included in Cost of revenues, Selling, general and administrative and/or Research and development based on the function that the underlying leased asset supports, which are reflected on the Condensed Consolidated Statements of Operations.

2    Reflects impairments recorded for the 7th floor at Bridgewater, NJ lease in the current period, and for Bethlehem, PA in the prior period.

3    For the nine months ended September 30, 2025, the sublease income includes a receipt of a $1.6 million past due sublease payment, for which we previously recorded an allowance for credit losses.

18

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

The following table provides the undiscounted amount of future cash flows included in the Company’s lease liabilities at September 30, 2025, for each of the five years beginning January 1, 2025 and thereafter, as well as a reconciliation of such undiscounted cash flows to our lease liabilities as of September 30, 2025:

						Operating Leases						Finance Leases
2025						$	1,812					$	495
2026						7,231						1,126
2027						4,938						650
2028						2,925						213
Total future lease payments						16,906						2,484
Less: amount representing interest						(1,616)						(237)
Present value of future lease payments (lease liability)						$	15,290					$	2,247

The following table provides the weighted average remaining lease term and weighted-average discount rates for our leases:

			September 30, 2025						December 31, 2024
Weighted average remaining lease term (years), weighted based on lease liability balances:
Finance leases			2.4						2.0
Operating leases			2.8						3.7
Weighted average discount rate (percentages), weighted based on the remaining balance of lease payments:
Finance leases			10.8%						10.0%
Operating leases			8.0%						8.0%

The following table provides certain cash flow and supplemental noncash information related to our lease liabilities:

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
Cash paid for amounts included in the measurement of lease liabilities:
Finance leases			$	299					$	186					$	679					$	534
Operating leases			1,797						1,924						5,617						5,848
Lease liabilities arising from obtaining right-of-use assets:
Finance leases			$	1,081					$	178					$	1,478					$	283
Operating leases			—						—						—						—

19

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 9. Debt

2025 Term Loan

On April 24, 2025 (the “Closing Date”), the Company and certain of its subsidiaries entered into the First Amendment to Credit Agreement and Pledge and Security Agreement (the “2025 Term Loan Agreement”) with the lenders party thereto and BGC Lender Rep LLC, as administrative agent, which amended the 2024 Term Loan Agreement (as defined below), to establish a new term loan facility in an aggregate principal amount of $200.0 million (the “2025 Term Loan”), all of which was funded on the Closing Date, with any existing lenders under the 2024 Term Loan Agreement participating pursuant to a cashless settlement of the $73.6 million outstanding aggregate principal amount of the 2024 Term Loan, as defined below, for total net cash proceeds of $126.4 million. In connection with the 2024 Term Loan settlement, the Company paid a $2.8 million make-whole provision. The proceeds from the 2025 Term Loan, together with cash on hand, were used to redeem all of the $121.4 million outstanding aggregate principal amount of 2021 Senior Notes on May 12, 2025 at the applicable redemption price. The Company paid a $1.2 million prepayment premium in connection with the 2021 Senior Notes redemption.

The 2025 Term Loan included participation from both existing and new lenders. One lender participated in both the 2024 Term Loan and the 2025 Term Loan. In addition, one former 2021 Senior Notes lender also participated in the 2025 Term Loan. These transactions were evaluated under ASC 470-50, Debt—Modifications and Extinguishments, and were accounted for as debt modifications. Those lenders from the 2021 Senior Notes that did not participate in the 2025 Term Loan (the “Extinguished Note Holders”) were considered extinguished under the accounting guidance. There was one new lender who also participated in the 2025 Term Loan syndicate.

In connection with the refinancing, the Company incurred $9.0 million of financing-related costs, consisting of $4.0 million in lender fees (treated as original issue discount) and $5.0 million in third-party costs. The Company capitalized the full $4.0 million in lender fees and $0.6 million of third-party costs as debt issuance costs, which will be amortized over the term of the 2025 Term Loan using the effective interest method. The remaining $4.4 million of third-party fees were recognized as Debt modification expense on the Condensed Consolidated Statements of Income for the nine months ended September 30, 2025, in accordance with ASC 470-50.

As of the Closing Date, the Company had $5.6 million of unamortized debt issuance costs associated with the 2024 Term Loan. These costs, along with the $2.8 million make-whole provision paid at refinancing, were capitalized and are being amortized over the term of the 2025 Term Loan.

The Company also had $2.1 million in unamortized debt issuance costs related to the 2021 Senior Notes. Of this amount, $0.8 million was allocated to lenders determined to be modified and will be amortized over the term of the 2025 Term Loan. The remaining $1.3 million was recognized as Loss on debt extinguishment on the Condensed Consolidated Statements of Income for the nine months ended September 30, 2025. Of the $1.2 million prepayment premium paid on the 2021 Senior Notes, $0.5 million was capitalized and will be amortized over the life of the 2025 Term Loan, while $0.7 million was recorded as Loss on debt extinguishment on the Condensed Consolidated Statements of Income for the nine months ended September 30, 2025.

The 2025 Term Loan also (i) lowered the consolidated secured leverage ratio, (ii) added covenant testing monthly with respect to a minimum number of subscribers under certain material contracts and (iii) provided for certain other changes to the terms of the 2025 Term Loan Agreement, including with respect to certain negative covenants.

The 2025 Term Loan will mature on April 24, 2029 (subject to an earlier springing maturity date that is nine months prior to the effective date of termination, forfeiture, non-renewal, cancellation, revocation or suspension of certain material contracts if unreplaced in accordance with the terms of the 2025 Term Loan Agreement) and bear an interest rate of the secured overnight financing rate, which shall not be less than 2.50%, plus a margin of 7.00% per annum (with one 0.50% stepdown at specified leverage).

The Company is required to repay the outstanding principal amounts of the 2025 Term Loan on a quarterly basis in an amount of $1.3 million beginning on July 24, 2025 and ending on April 24, 2026; $2.5 million beginning on July 24, 2026 and ending on April 24, 2027; $3.8 million beginning on July 24, 2027 and ending on April 24, 2028. Starting on July 24, 2028, on

20

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

the 24th day of each July, October, January and April thereafter, such repayments of outstanding principal are to be $5.0 million. The final principal repayment of the 2025 Term Loan is to be repaid on the Maturity Date in an amount equal to the aggregate principal amount of the 2025 Term Loan outstanding on such date. These quarterly principal payment amounts shall be reduced as a result of the application of prepayments in accordance with the order of priority set forth in Section 2.7(i) of the 2025 Term Loan Agreement as described below. The Company is permitted to at any time voluntarily prepay the 2025 Term Loan, in whole or in part subject to a variable prepayment fee if such prepayment was made prior to the third anniversary of the Closing Date.

In July 2025, the Company received the expected tax refund from the 2020 CARES Act of $33.9 million, which included $5.2 million of interest. In accordance with the terms of the 2025 Term Loan Agreement, 75% of the total amount, or $25.4 million, was used to pay down the 2025 Term Loan at par. The $25.4 million principal prepayment satisfied the required quarterly principal payments (as disclosed above), including the current portion, through approximately January 2028. Accordingly, as of September 30, 2025, the Company has no remaining contractual payments due on the principal balance of its long term debt for the next 12 months. As a result of this prepayment, $1.7 million of the unamortized deferred financing costs related to the 2025 Term Loan were recognized as interest expense in the third quarter of 2025.

The Company was in compliance with its debt covenants pertaining to the 2025 Term Loan as of September 30, 2025.

The Company’s obligations under the 2025 Term Loan Agreement are secured by substantially all of the assets (other than existing real property) of the Company. Other than an Irish Subsidiary (as defined in the 2025 Term Loan Agreement), none of the Company’s direct or indirect foreign subsidiaries or immaterial subsidiaries has guaranteed the loans under the 2025 Term Loan Agreement, but under certain circumstances, such subsidiaries may become guarantors. The 2025 Term Loan Agreement contains customary covenants that limit the Company’s ability and its restricted subsidiaries to, among other things, (i) incur additional indebtedness, (ii) pay dividends or make certain other restricted payments, (iii) sell assets, (iv) make certain investments, (v) grant liens and (vi) enter into transactions with affiliates. These covenants are subject to exceptions and qualifications set forth in the 2025 Term Loan Agreement. The financial covenants set forth in the 2025 Term Loan Agreement include (i) a maximum consolidated secured leverage ratio of greater than 6.30 to 1.00, which will be tested at the end of each of the Company’s fiscal quarters (ii) a covenant tested monthly with respect to a minimum number of subscribers under certain material contracts and (iii) an average liquidity requirement for any calendar month. All borrowings under the 2025 Term Loan Agreement are subject to the satisfaction of customary conditions, including the absence of a default and the accuracy of representations and warranties subject to certain exceptions. The 2025 Term Loan Agreement also contains mandatory prepayment provisions that are customary for secured financings of this type from excess cash flow and with the proceeds of certain asset sales, tax refunds, equity sales or issuances, and debt issuances, each as more fully described in the 2025 Term Loan Agreement. Upon the occurrence and continuance of an event of default, which, for example, would be triggered by a breach or violation of, default under, cancellation, termination, forfeiture, rescission, revocation, suspension, impairment or non-renewal of certain material contracts of the Company, BGC Lender Rep may take either or both of the following actions: (i) terminate the commitments and (ii) declare all outstanding obligations immediately due and payable and take such other actions as set forth in the 2025 Term Loan Agreement.

2024 Term Loan

On June 28, 2024 (the “Effective Date”), the Company entered into a Credit Agreement (the “Original Credit Agreement”, as amended by the 2025 Term Loan Agreement (as defined above), the “2024 Term Loan Agreement”) with BGC Lender Rep LLC, as administrative agent, and the lenders party thereto. The 2024 Term Loan Agreement established a senior secured term loan facility of up to $75.0 million (the “2024 Term Loan”), all of which was funded on the Effective Date. The proceeds of the 2024 Term Loan were used to (i) fund the repurchase of $19.7 million of the Company’s 8.375% Senior Notes due 2026 (the “2021 Senior Notes”), for an aggregate purchase price of $16.5 million, (ii) to fund the repurchase of 60,826 shares of its Series B Perpetual Non-Convertible Preferred Stock (the “Series B Preferred”), for an aggregate purchase price of $52.6 million (the “Series B Repurchase”), and (iii) to pay transaction fees and expenses associated with the closing of the transactions contemplated by the 2024 Term Loan Agreement.

The 2024 Term Loan was to mature on June 28, 2028 (the “Maturity Date”), subject to certain adjustments to such maturity date pursuant to the terms of the 2024 Term Loan Agreement. The 2024 Term Loan bore interest at a rate per annum equal to

21

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

the Adjusted Term Secured Overnight Financing Rate (as defined in the 2024 Term Loan Agreement) for the applicable interest period, plus 5.50%, subject to a floor of 2.50%.

In line with the terms of the 2024 Term Loan Agreement, the Company made $0.5 million of principal payments on the 2024 Term Loan for the nine months ending September 30, 2025 until the Company entered into the 2025 Term Loan as described above, and $0.5 million of principal payments for the nine months ending September 30, 2024.

Redemption of 2024 Term Loan

On April 24, 2025 the 2024 Term Loan was repaid in full pursuant to a cashless settlement of the $73.6 million then outstanding aggregate principal amount on the Closing Date (as defined above) in connection with the 2025 Term Loan (as defined above).

2021 Senior Notes

On June 30, 2021, the Company closed its underwritten public offering of $120.0 million aggregate principal amount of 8.375% senior notes due 2026 at a par value of $25.00 per senior note (the “Senior Notes”). The offering was conducted pursuant to an underwriting agreement (the “Notes Underwriting Agreement”) dated June 25, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters (the “Notes Underwriters”). At the closing, the Company issued $125.0 million aggregate principal amount of Senior Notes, inclusive of $5.0 million aggregate principal amount of Senior Notes issued pursuant to the full exercise of the Notes Underwriters’ option to purchase additional Senior Notes.

On June 30, 2021, the Company entered into an indenture (the “Base Indenture”) and a supplemental indenture (the “First Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) with The Bank of New York Mellon Trust Company National Association, as trustee (the “Trustee”), between the Company and the Trustee. The Indenture establishes the form and provides for the issuance of the Senior Notes.

The Senior Notes were senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s existing and future senior unsecured and unsubordinated indebtedness. The Senior Notes were effectively subordinated in right of payment to all of the Company’s existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness and structurally subordinated to all existing and future indebtedness of the Company’s subsidiaries, including trade payables. The Senior Notes bore interest at the rate of 8.375% per annum. Interest on the Senior Notes was payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, commencing on July 31, 2021. The Senior Notes were to mature on June 30, 2026, unless redeemed prior to maturity.

On October 25, 2021, the Company entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) between the Company and B. Riley Securities, Inc. (the “Agent”), a related party, pursuant to which the Company may offer and sell, from time to time, up to $18.0 million of the Company’s 8.375% Senior Notes due 2026. Sales of the additional Senior Notes pursuant to the Sales Agreement, if any, might be made in transactions that were deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). Under the Sales Agreement, the Agent would be entitled to compensation of 2.0% of the gross proceeds of all notes sold through it as the Company’s agent.

During the fourth quarter of 2021, the Company sold an additional $16.1 million aggregate principal amount of Senior Notes pursuant to the Sales Agreement. The additional Senior Notes sold had terms identical to the initial Senior Notes and were fungible and vote together with, the initial Senior Notes. The Senior Notes were listed and traded on The Nasdaq Global Market under the symbol “SNCRL.”

22

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Repurchase of 2021 Senior Notes and Series B Preferred

On June 28, 2024, the Company used $66.5 million of the proceeds from the 2024 Term Loan and $2.6 million non-interest-bearing deferred consideration, which was paid to BRPI in December of 2024, for a total consideration of $69.1 million (“the total consideration”) to repurchase 100% of its outstanding Series B Perpetual Non-Convertible Preferred Stock (the “Series B Preferred”) and 787,590 (14%) of its outstanding Senior Notes from BRPI, a related party.

The fair value of Series B Preferred stock of $57.6 million was determined using a discounted cash flow model using level two inputs. The carrying value of Series B Preferred was $58.2 million. The second quarter’s accrued dividend of $2.1 million was forgiven at the time of the repurchase. The Series B Preferred repurchase gain of $2.7 million was calculated as the fair value of consideration paid less the carrying value, less the second quarter’s accrued dividend forgiven. The $2.7 million gain was accounted for as capital transaction and reflected as an adjustment to additional paid-in capital (“APIC”). While the transaction was not reflected in the income statement, the gain was reflected in the adjustment to net income from common shareholders for purposes of calculating EPS, for the nine months ended September 30, 2024.

The Company allocated $57.6 million of the total consideration to the Series B Preferred based on the fair value and allocated the remaining consideration of $11.5 million to the Senior Notes repurchase. The carrying value of Senior notes repurchased was $19.1 million including $0.6 million of unamortized debt issuance costs. The second quarter’s accrued interest of $0.3 million was forgiven at the time of the repurchase. The Senior Note Repurchase gain of $7.9 million was calculated as the remaining consideration paid of $11.5 million less the carrying value, less the second quarter’s accrued interest forgiven. The Company accounted for the debt repurchase as a redemption with a related party. ASC 470-50-40-2 indicates that such an extinguishment transaction may be in essence a capital transaction. Therefore, the transaction was accounted for as a capital transaction and reflected as an adjustment to APIC, which resulted in a gain of $7.9 million for the nine months ended September 30, 2024.

Redemption of 2021 Senior Notes

On May 12, 2025 the Company used $122.6 million of the proceeds from the 2025 Term Loan to repurchase 100% of its outstanding 2021 Senior Notes as described above.

23

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Carrying Value of Debt

The carrying amounts of the Company’s borrowings were as follows:

						September 30, 2025						December 31, 2024
2021 Senior Notes:
Senior Notes						$	—					$	121,387
Unamortized discount and debt issuance cost1						—						(2,625)
Carrying value of Senior Notes						—						118,762
2024 Term Loan:
Term Loan						—						74,063
Unamortized debt issuance cost1						—						(6,110)
Carrying value of 2024 Term Loan						—						67,953
2025 Term Loan:
Term Loan						174,599						—
Unamortized debt issuance cost1						(11,399)						—
Carrying value of 2025 Term Loan						163,200						—
Total carrying value of debt						$	163,200					$	186,715
Current portion of long-term debt						$	—					$	1,875
Long-term debt, net of current portion						$	163,200					$	184,840

________________________________

1    Debt issuance costs are deferred and amortized into interest expense using the effective interest method.

Fair Value of Debt

The fair value of the 2025 Term Loan was obtained using the Discounted Cash Flow (“DCF”) valuation model with observable inputs as of September 30, 2025 and is categorized accordingly as Level 2 in the fair value hierarchy.

						Balance at September 30, 2025
												Fair Value
						Carrying Amount						(Level 1)						(Level 2)						(Level 3)						Total
Total debt						$	163,200					$	—					$	171,713					$	—					$	171,713

						Balance at December 31, 2024
												Fair Value
						Carrying Amount						(Level 1)						(Level 2)						(Level 3)						Total
Total debt						$	186,715					$	—					$	193,275					$	—					$	193,275

24

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Interest Expense

The following table summarizes the Company’s interest expense:

						Three Months Ended September 30,															Nine Months Ended September 30,
						2025						2024												2025						2024
2021 Senior Notes:
Amortization of debt issuance costs and discount						$	—					$	391											$	522					$	1,269
Interest on borrowings						—						2,541												3,699						8,449
2024 Term Loan:
Amortization of debt issuance costs						—						293												483						301
Amortization of exit fee						—						64												(151)						66
Interest on borrowings						—						2,118												2,304						2,163
2025 Term Loan:
Amortization of debt issuance costs1						2,386						—												2,964						—
Interest on Borrowings						5,224						—												9,484						—
Other2						166						119												458						281
Total interest expense						$	7,776					$	5,526											$	19,763					$	12,529

________________________________

1    Includes $1.7 million of additional amortization due to $25.4 million principal repayment due to federal tax refund receipt as described above.

2    Includes interest on uncertain tax provisions.

Note 10. Accumulated Other Comprehensive (Loss) Income

The changes in accumulated other comprehensive (loss) income during the nine months ended September 30, 2025 were as follows:

			Balance at December 31, 2024						Other Comprehensive Income						Tax Effect						Balance at September 30, 2025
Foreign currency			$	(37,617)					$	27,968					$	—					$	(9,649)
Unrealized loss on intercompany foreign currency transactions			(3,520)						—						—						(3,520)
Total			$	(41,137)					$	27,968					$	—					$	(13,169)

25

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 11. Capital Structure

As of September 30, 2025, the Company’s authorized capital stock was 26,666,667 shares of stock with a par value of $0.0001, of which 16,666,667 shares were designated as common stock and 10,000,000 shares were designated as preferred stock.

Common Stock

Each holder of common stock is entitled to vote on all matters and is entitled to one vote for each share held. Dividends on common stock will be paid when, and if, declared by the Company’s Board of Directors. No dividends have ever been declared or paid by the Company.

Treasury Stock

The Company’s Treasury Stock balance is nil as of September 30, 2025.

Preferred Stock

The Company’s Board of Directors (the “Board”) is authorized to issue preferred shares and has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences of preferred stock.

Series B Non-Convertible Preferred

On June 30, 2021, the Company closed a private placement of 75,000 shares of its Series B Perpetual Non-Convertible Preferred Stock, par value $0.0001 per share, with an initial liquidation preference of $1,000 per share (the “Series B Preferred”), for net proceeds of $72.8 million (the “Series B Transaction”). The sale of the Series B Preferred was pursuant to the Series B Preferred Stock Purchase Agreement, dated as of June 24, 2021 (the “Series B Purchase Agreement”), between the Company and BRPI. In connection with the closing of the Series B Transaction, the Company (i) filed a Certificate of Designation with the State of Delaware setting forth the rights, preferences, privileges, qualifications, restrictions and limitations on the Series B Preferred (the “Series B Certificate”) and (ii) entered into an Investor Rights Agreement with B. Riley Financial, Inc. (“B. Riley Financial”) and BRPI setting forth certain governance and registration rights of B. Riley Financial with respect to the Company.

Repurchase of Series B Preferred

On June 28, 2024 the Company repurchased all outstanding shares of the Series B Preferred stock, as discussed in Note 9. Debt of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q. On July 1, 2024 the Company filed a Certificate of Elimination to the Series B Certificate with the Secretary of State of the State of Delaware. As a result of the Series B Repurchase, zero shares of the Series B Preferred remain outstanding and none are authorized for issuance as of

26

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

September 30, 2025, and the authorized shares of Series B Preferred Stock were returned to the status of authorized but unissued shares of preferred stock of the Company, without designation as to series pursuant to the Certificate of Designations.

The fair value of Series B Preferred stock of $57.6 million was determined using a discounted cash flow model using level two inputs. The carrying value of Series B Preferred was $58.2 million. The second quarter’s accrued dividend of $2.1 million was forgiven at the time of the repurchase. The Series B Preferred repurchase gain of $2.7 million was calculated as the fair value of consideration paid less the carrying value, less the second quarter’s accrued dividend forgiven. The $2.7 million gain was accounted for as capital transaction and reflected as an adjustment to additional paid-in capital (“APIC”). While the transaction was not reflected in the income statement, the gain was reflected in the adjustment to net income from common shareholders for purposes of calculating EPS, for the nine months ended September 30, 2024.

Zentry Partnership Termination

On December 31, 2015, the Company formed a joint venture with a third party, referred to as Zentry with the goal of accelerating the Company’s entrance into the enterprise market by adding identity management capabilities to the Synchronoss Secure Mobility Suite. The Company obtained a 67% interest in Zentry in exchange for $48.0 million. The Company and third party agreed to certain put and call options with regard to third party’s interest in Zentry. The Company determined that the put option was embedded within the noncontrolling interest shares that were subject to the put option. The redemption feature required the classification of third party’s minority interest in the Consolidated Balance Sheets outside of permanent equity under the caption Redeemable non-controlling interest. The venture was deemed not to be a VIE, as a result, the Company consolidated the venture in the consolidated financial statements according to the voting model.

During the second quarter of 2025, pursuant to the terms of a transfer and termination agreement, the Company and the other parties thereto agreed to terminate the Joint Venture Agreement dated as of December 31, 2024, and extinguished all rights and obligations in connection therewith. As a result, given the put option was no longer exercisable, the Company reduced the $12.5 million balance of Redeemable non-controlling interest to zero with a corresponding increase in Additional Paid-In Capital (“APIC”) on the Condensed Consolidated Balance Sheets.

Stock Plans

As of September 30, 2025, the Company maintains two stock-based compensation plans, the 2015 Equity Incentive Plan (the “2015 Plan”) and the 2017 New Hire Equity Incentive Plan (“2017 Plan”), under which the Company may grant to its employees, outside directors, and consultants awards in the form of stock options, shares of restricted stock, stock units, or stock appreciation rights and performance shares. As of September 30, 2025, the maximum number of shares of common stock authorized for issuance is 5,741,575 shares under the 2015 Plan and 229,635 shares under the 2017 Plan. As of September 30, 2025, there were 51,484 shares available for the grant or award under the Company’s 2015 Plan and 109,044 shares available for the grant or award under the Company’s 2017 Plan.

Stock Options

Stock options granted under the Company’s 2015 and 2017 Plans generally vest one-third of the applicable shares on the first, second, and third anniversary of the grant date, subject to continuous service. The Company accounts for stock options under equity accounting. Stock options are measured at fair value at the grant date using the Black-Scholes option pricing model and expense is recognized on a straight-line basis over the requisite service period. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.

Restricted Stock Awards

Restricted stock awards granted under the Company’s 2015 and 2017 Plans generally vest one-third of the applicable shares on the first, second, and third anniversary of the grant date, subject to continuous service. The Company accounts for these awards under equity accounting. Restricted stock awards are measured at the closing stock price at the grant date and expense is recognized on a straight-line basis over the requisite service period. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.

27

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Performance-Based Cash Units

Performance-based cash units (“PBCU”) are performance-based awards granted under the Company’s Long Term Incentive (“LTI”) Plans. PBCU are three-year grants tied to specific company performance metrics. Each year, the Compensation Committee establishes performance targets for the applicable performance period and PBCU are earned annually based on the achievement of these targets. All earned PBCU generally vest at the end of a three-year period assuming continuous employment as of the vesting date. The PBCU can be settled in cash or in equity as determined by the Compensation Committee, subject to the availability of shares for issuance as of the vesting date.

PBCU that are accounted for as equity awards are measured at the closing stock price at the grant date and expense is recognized on a straight-line basis over the requisite service period. The expense for the period will increase or decrease based on the percentage achievement of the performance metrics at each reporting date. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.

PBCU that are accounted for as liability awards are measured at the fair value at the reporting period end date and expense is recognized on a straight-line basis over the requisite service period. The expense for the period will increase or decrease based on updated fair values of these awards as well as the percentage achievement of the performance metrics at each reporting date. The short-term liability related to these awards is included in Accrued expenses and the long-term portion is included in Other liabilities, non-current on the Condensed Consolidated Balance Sheets.

The Company currently has three active LTI plans: 2023-2025 LTI Plan, 2024-2026 LTI Plan and 2025-2027 LTI Plan. As of September 30, 2025, the Company’s PBCU granted to employees under these three plans have been accounted for as liability awards, due to the Company’s intent and the ability to settle such awards in cash upon vesting and expected lack of shares available for issuance. As of September 30, 2025, the short-term liability for such awards was $0.4 million and the long-term liability was $1.3 million.

28

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by operating expense categories, as follows:

			Three Months Ended September 30,															Nine Months Ended September 30,
			2025						2024												2025						2024
Cost of revenues			$	60					$	164											$	218					$	258
Research and development			269						832												1,038						1,415
Selling, general and administrative			811						2,025												3,036						3,703
Total stock-based compensation expense			$	1,140					$	3,021											$	4,292					$	5,376

The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by award type, as follows:

			Three Months Ended September 30,															Nine Months Ended September 30,
			2025						2024												2025						2024
Awards classified as equity:
Stock options			$	7					$	123											$	156					$	453
Restricted stock awards			969						761												2,991						1,950
Performance-based cash units			—						—												381						463
Total equity classified awards			976						884												3,528						2,866
Awards classified as liability:
Performance-based cash units			164						2,137												764						2,510
Total stock-based compensation before taxes			$	1,140					$	3,021											$	4,292					$	5,376
Tax benefit			$	229					$	463											$	917					$	987

The total unamortized stock-based compensation cost related to unvested restricted stock awards and stock options as of September 30, 2025 was $5.9 million. The expense is expected to be recognized over a weighted-average period of approximately 2.0 years.

The total unamortized stock-based compensation cost related to unvested performance-based cash units as of September 30, 2025 was $1.6 million. The expense is expected to be recognized over a weighted-average period of approximately 1.8 years.

29

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Note 12. Restructuring

The Company continues to identify workforce optimization opportunities to better align the Company’s resources with its key strategic priorities.

A summary of the Company’s restructuring accrual at September 30, 2025 and changes during the nine months ended September 30, 2025, are presented below:

						Employee Termination Costs
Balance at December 31, 2024						$	712
Charges						165
Payments						(877)
Balance at September 30, 2025						$	—

Note 13. Income Taxes

The Company recognized income tax benefit of approximately $1.8 million and income tax expense of approximately $0.6 million for the three months ended September 30, 2025 and 2024, respectively. The effective tax rate was approximately (44.7)% for the three months ended September 30, 2025, which was lower than the U.S. federal statutory rate, primarily due to the discrete tax benefit recorded in the period. The Company finalized its 2024 U.S. federal income tax return during the period, which resulted in a discrete tax benefit of $1.7 million primarily attributable to research tax credit and foreign tax credit studies completed prior to filing the tax return. The Company’s effective tax rate was approximately (12.3)% for the three months ended September 30, 2024, which was lower than the U.S. federal statutory rate primarily due to the impact of permanent adjustments including Global Intangible Low-Taxes Income and adjustments to valuation allowances associated with prior year activity, partially offset by foreign tax rate differential.

The Company recognized income tax expense of approximately $0.7 million and $3.9 million during the nine months ended September 30, 2025 and 2024, respectively. The effective tax rate was approximately (4.4)% for the nine months ended September 30, 2025, which was lower than the U.S. federal statutory rate due to the current period loss from operations before taxes, the impact of permanent adjustments, including Global Intangible Low-Taxed Income, decreased the effective tax rate, while the impact of foreign tax rate differential, and the impact of valuation allowances increased the effective tax rate. In addition, the Company finalized its 2024 U.S. federal income tax return during the period, which resulted in a discrete tax benefit of $1.7 million primarily attributable to research tax credit and foreign tax credit studies completed prior to filing the tax return. The Company’s effective tax rate was approximately 178.6% for the nine months ended September 30, 2024, which was higher than the U.S. federal statutory rate primarily due to the impact of permanent adjustments, most notably Global Intangible Low-Taxed Income, partially offset by foreign tax rate differential. The Company continues to consider all available evidence, including historical profitability and projections of future taxable income together with new evidence, both positive and negative, that could affect the view of the future realization of deferred tax assets. As a result of this assessment, the Company continues to record a valuation allowance against the net deferred tax assets of certain jurisdictions as the realization of these assets is not more likely than not, given uncertainty of future earnings in these jurisdictions.

Unrecognized tax benefits associated with uncertain tax positions were $4.4 million at September 30, 2025. We are not able to reasonably estimate when we would make any cash payments required to settle these liabilities, but we do not believe that the ultimate settlement of our obligations will materially affect our liquidity. The Company anticipates that $3.8 million of its currently unrecognized tax benefits, primarily related to research and development credits and other U.S. tax positions, may be recognized within the next 12 months as a result of a lapse of the statute of limitations.

During 2021 the Internal Revenue Service commenced an audit of certain of the Company’s prior year U.S. federal income tax filings, including the 2013 through 2020 tax years. In July 2025, the Company received the full IRS refund of $33.9 million, which included $5.2 million of interest income. This interest income is included within the Consolidated Statements of Operations for the three and nine months ending September 30, 2025.

30

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

The Pillar Two Global Anti-Base Erosion rules issued by the Organization for Economic Co-operation and Development ("OECD"), a global policy forum, introduced a global minimum tax of 15% which would apply to multinational groups with consolidated financial statement revenue in excess of EUR 750 million. Nearly all OECD member jurisdictions have agreed in principle to adopt these provisions and numerous jurisdictions, including jurisdictions where the Company operates, have enacted these rules effective January 1, 2024. The Company is not currently subject to these rules but is continuing to evaluate the Pillar Two Framework and its potential impact on future periods.

On July 4, 2025, the U.S. government enacted The One Big Beautiful Bill Act of 2025 which includes, among other provisions, changes to the U.S. corporate income tax system including the allowance of immediate expensing of domestic research and development expenses and permanent extensions of certain provisions within the Tax Cuts and Jobs Act. Certain provisions, such as the immediate expensing of U.S. domestic research and development costs and 100 percent bonus depreciation are effective for the Company beginning in 2025, while others will be effective in 2026. The Company has incorporated the anticipated impact of this legislation, into its financial statements for the period ending September 30, 2025. The primary impact in the period is a decrease in anticipated 2025 U.S. federal and state current income tax expense.

Note 14. Earnings per Common Share (“EPS”)

Basic EPS is computed based upon the weighted average number of common shares outstanding for the year. Diluted EPS is computed based upon the weighted average number of common shares outstanding for the year plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of the Company’s common stock for the year. The Company includes participating securities (such as performance-based cash unit awards) in the computation of EPS pursuant to the two-class method. The two-class method of computing earnings per share is an allocation method that calculates earnings per share for common stock and participating securities. During periods of net loss, no effect is given to the participating securities because they do not share in the losses of the Company.

31

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income attributable to common stockholders per common share from operations.

			Three Months Ended September 30,															Nine Months Ended September 30,
			2025						2024												2025						2024
Numerator - basic:
Net income (loss)			$	5,813					$	(5,715)											$	(17,608)					$	(1,734)
Net income attributable to redeemable non-controlling interests			—						14												—						14
Preferred stock dividend, net of gain on repurchase of preferred stock			—						—												—						(1,562)
Net income (loss) attributable to Synchronoss			5,813						(5,701)												(17,608)						(3,282)
Numerator - diluted:
Net income (loss) attributable to Synchronoss			$	5,813					$	(5,701)											$	(17,608)					$	(3,282)
Denominator:
Weighted average common shares outstanding — basic			10,632						10,095												10,357						9,994
Dilutive effect of:
Shares from assumed conversion of PBCU			807						—												—						—
Options and unvested restricted shares			34						—												—						—
Weighted average common shares outstanding — diluted			11,473						10,095												10,357						9,994
Earnings (loss) per share:
Basic			$	0.55					$	(0.56)											$	(1.70)					$	(0.33)
Diluted			$	0.51					$	(0.56)											$	(1.70)					$	(0.33)
Anti-dilutive stock options and restricted stock awards1			1,122						466												805						528

________________________________

1    Represent stock options and restricted stock awards excluded from the Diluted EPS calculations because the effect would be anti-dilutive.

Note 15. Commitments

Non-cancelable Agreements

The Company has various non-cancelable arrangements such as services for hosting, support, and software that expire at various dates, with the latest expiration in 2028.

32

Table of Content

SYNCHRONOSS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED

(Amounts in tables in thousands, except for per share data or unless otherwise noted)

Aggregate annual future minimum payments under non-cancelable agreements as of September 30, 2025 for each year beginning January 1, 2025, are as follows:

						Non-cancelable Agreements
2025						$	4,275
2026						12,293
2027						10,691
2028						6,366
Total						$	33,625

Note 16. Legal Matters

In the ordinary course of business, the Company is regularly subject to various claims, suits, regulatory inquiries and investigations. The Company records a liability for specific legal matters when it determines that the likelihood of an unfavorable outcome is probable, and the loss can be reasonably estimated. Management has also identified certain other legal matters where they believe an unfavorable outcome is not probable and, therefore, no reserve is established. Although management currently believes that resolving claims against the Company, including claims where an unfavorable outcome is reasonably possible, will not have a material impact on the Company’s business, financial position, results of operations, or cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. The Company also evaluates other contingent matters, including income and non-income tax contingencies, to assess the likelihood of an unfavorable outcome and estimated extent of potential loss. It is possible that an unfavorable outcome of one or more lawsuits or other contingencies could have a material impact on the liquidity, results of operations, or financial condition of the Company.

The Company is not currently subject to any legal proceedings that would be expected to have a material adverse effect on its operations; however, the Company may from time to time become a party to various legal proceedings arising in the ordinary course of its business.

33

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes included in Item 1 “Financial Information” of this Form 10-Q.

Forward-looking Statements

This Quarterly Report on Form 10-Q, as well as information included in oral statements or other written statements made or to be made by us, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this report, including statements regarding our future results of operations and financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “could,” “would,” “project,” “target,” “plan,” “expect,”, “seek,” “hope,” “likely,” or the negative of these terms or other similar expressions.

Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, including risks described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q that may cause actual results to differ materially from those anticipated or implied by the forward-looking statements. These factors include, but are not limited to:

•Adverse changes in the national and global economic environments, including foreign currency exchange and tariffs could affect our sales, revenue and profitability;

•Changes in market trends, growth rates and consumer preferences could impact our ability to meet customer demands, launch new products or features successfully, attract and retain new customers, or to successfully compete with other providers of similar products;

•New laws, regulations or changes to existing laws or regulations, including economic and trade policy, taxation and data protection, could increase our operational complexity or cost;

•Failure to anticipate and keep up with technological advancements could impair our competitiveness;

•Security breaches or cyber-attacks could compromise our proprietary information, cause reputational harm and result in financial penalties;

•The sufficiency of and our ability access cash or cash equivalents to meet our liquidity needs, the timing of our federal tax refund, capital expenditures, fluctuations in interest rates or credit availability could impact our financial performance;

•Legal proceedings or changes in the legal environment could affect our business operations and financial condition;

•Pandemic outbreaks, geopolitical tensions or natural disasters could disrupt our operations;

•Our ability to attract and retain talented employees is crucial to our success and any shortfall in that area could impact our operations.

Given these risks and uncertainties, undue reliance should not be placed on such forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in, or implied by, any forward-looking statements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report or to conform these statements to actual results or to changes in our expectations. You should read this Quarterly Report on Form 10-Q and the documents that we have filed as exhibits to this report with the understanding that our actual future results, levels of activity, performance, and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.

Investors, the media, and others should note that we intend to announce material information to the public through filings with the Securities and Exchange Commission (SEC), the investor relations page on our website (https://

34

Table of Contents

synchronosstechnologiesinc.gcs-web.com/), press releases, public conference calls, webcasts and social media channels, including our X (formerly known as Twitter) feed (x.com/synchronoss) and LinkedIn page (https://www.linkedin.com/company/synchronoss-technologies). The information disclosed by the foregoing channels could be deemed to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor relations page on our website. The contents of the websites provided above are not incorporated into this filing or in any other report or document we file with the SEC. These website addresses are intended to be inactive textual references only.

Overview

Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) is a leading provider of white label cloud software and services that enable our customers to keep subscribers, systems, networks, and content in sync.

The Synchronoss Personal CloudTM platform is a secure and highly scalable white label platform that allows our customers’ subscribers to backup and protect, engage with, and manage their personal content and gives our operator customers the ability to increase average revenue per user (“ARPU”) and reduce churn.

Designed for smartphones, tablets, and desktops across all operating systems, our platform ensures a seamless cross-device experience.

We market our solutions through multiple channels such as our corporate website, direct sales teams across key regions (North America, Europe, Middle East and Africa (“EMEA”) and Asia-Pacific (“APAC”)), and industry partnerships.

Revenues

We generate most of our revenues on a subscription basis, which is derived from customer contracts with terms ranging from three to five years.

The future success of our business depends on the continued growth of Business-to-Business (“B2B”) and Business-to-Business-to-Consumer driving customer transactions, and continued expansion of our platforms into the telecom (“TMT”) market globally through cloud markets. As such, the volume of subscribers and our ability to expand our footprint in TMT and globally may result in revenue fluctuations on a quarterly basis.

Most of our revenues are recorded in U.S. dollars, but as we continue to expand our footprint with international carriers, we are subject to currency translation that could affect our future net sales as reported in U.S. dollars.

The Company’s top five customers accounted for 99.1% and 97.9% of net revenues for the nine months ended September 30, 2025 and September 30, 2024, respectively. Contracts with these customers typically run for three to five years. Of these customers, both Verizon and AT&T accounted for more than 10% of our revenues in 2025 and 2024. The loss of Verizon or AT&T as a customer would have a material negative impact on our company. However, we believe the costs incurred by and subscriber disruption for Verizon or AT&T to replace Synchronoss’ solutions would be substantial.

Current Trends Affecting Our Results of Operations

Business from our Synchronoss Personal Cloud™ solution has been driven by the growth in mobile devices globally that are becoming content rich. As these devices replace other traditional devices like PCs, the ability to securely back up content from mobile devices, sync it with other devices and share it with family, friends, and business associates has become an essential need and subscriber expectation. Such devices include smartphones, connected cars, personal health and wellness devices, and connected home devices. The need for the content from these devices to be stored in a common cloud is also expected to drive our business in the longer term.

35

Table of Contents

Discussion of the Condensed Consolidated Statements of Operations

Three months ended September 30, 2025 compared to the three months ended September 30, 2024

The following table presents an overview of our results of operations for the three months ended September 30, 2025 and 2024 (in thousands):

						Three Months Ended September 30,												Change
						2025						2024												2025 vs 2024
Net revenues						$	42,003					$	42,964											$	(961)
Costs and expenses:
Cost of revenues1						8,665						8,975												(310)
Research and development						10,837						10,333												504
Selling, general and administrative						12,174						13,755												(1,581)
Depreciation and amortization						4,458						4,386												72
Total costs and expenses						36,134						37,449												(1,315)
Income from operations						5,869						5,515												354
Interest income						5,404						165												5,239
Interest expense						(7,776)						(5,526)												(2,250)
Foreign exchange gain (loss)						512						(5,461)												5,973
Other income, net						8						220												(212)
Income (loss) from operations, before taxes						4,017						(5,087)												9,104
Provision for income taxes						1,796						(628)												2,424
Net income (loss)						$	5,813					$	(5,715)											$	11,528

________________________________

1    Cost of revenues excludes depreciation and amortization which are shown separately.

Net revenues decreased $1.0 million to $42.0 million for the three months ended September 30, 2025, compared to the same period in 2024. The decrease in revenue was primarily attributable to $0.8 million decrease in professional services, including $1.5 million impact of a customer contract that expired in the prior period, partially offset by subscriber growth.

Cost of revenues decreased $0.3 million to $8.7 million for the three months ended September 30, 2025, compared to the same period in 2024. The decrease in 2025 was primarily driven by the elimination of certain third-party service costs following the Company’s transition of related activities to internal operations.

Research and development expense increased $0.5 million to $10.8 million for the three months ended September 30, 2025, compared to the same period in 2024. The increase in 2025 was primarily attributable to higher personnel-related costs.

Selling, general and administrative expense decreased $1.6 million to $12.2 million for the three months ended September 30, 2025, compared to the same period in 2024. Selling, general and administrative expenses decreased primarily due to $1.3 million lower performance-based compensation expense in the current period due to expected full-year metric attainment compared to the prior period performance.

Depreciation and amortization expense increased $0.1 million for the three months ended September 30, 2025, compared to the same period in 2024. The 2025 increase was primarily attributable to increased amortization of capitalized software due to more amortizable assets placed in service in the current period.

Interest income increased $5.2 million to $5.4 million for the three months ended September 30, 2025, compared to the same period in prior year primarily due to $5.2 million interest income related to the federal tax refund received by the Company during the third quarter of 2025.

36

Table of Contents

Interest expense increased $2.3 million to $7.8 million for the three months ended September 30, 2025, compared to the same period in 2024. The increase in interest expense is attributable to $0.5 million higher interest on the 2025 Term Loan and $1.7 million amortization of deferred financing costs accelerated due to 2025 Term Loan principal prepayment in the current period.

Foreign exchange (loss) gain was a gain of $0.5 million compared to a loss of $5.5 million for the three months ended September 30, 2025 and 2024, respectively, due to the impact of non-cash foreign exchange losses on intercompany payables and receivables primarily between the Company’s U.S. and European entities.

Income tax. The Company recognized income tax benefit of approximately $1.8 million and income tax expense of approximately $0.6 million for the three months ended September 30, 2025 and 2024, respectively. The effective tax rate was approximately (44.7)% for the three months ended September 30, 2025, which was lower than the U.S. federal statutory rate, primarily due to the discrete tax benefit recorded in the period. The Company finalized its 2024 U.S. federal income tax return during the period, which resulted in a discrete tax benefit of $1.7 million primarily attributable to research tax credit and foreign tax credit studies completed prior to filing the tax return. The Company’s effective tax rate was approximately (12.3)% for the three months ended September 30, 2024, which was lower than the U.S. federal statutory rate primarily due to the impact of permanent adjustments including Global Intangible Low-Taxes Income and adjustments to valuation allowances associated with prior year activity, partially offset by foreign tax rate differential.

Nine months ended September 30, 2025 compared to the nine months ended September 30, 2024

The following table presents an overview of our results of operations for the nine months ended September 30, 2025 and 2025 (in thousands):

						Nine Months Ended September 30,												$ Change
						2025						2024												2025 vs 2024
Net revenues						$	126,702					$	129,387											$	(2,685)
Costs and expenses:
Cost of revenues1						26,298						29,599												(3,301)
Research and development						30,939						32,560												(1,621)
Selling, general and administrative						35,404						39,800												(4,396)
Restructuring charges						165						267												(102)
Depreciation and amortization						12,938						12,773												165
Total costs and expenses						105,744						114,999												(9,255)
Income from operations						20,958						14,388												6,570
Interest income						5,906						556												5,350
Interest expense						(19,763)						(12,529)												(7,234)
Debt modification expense						(4,384)						—												(4,384)
Loss on debt extinguishment						(1,993)						—												(1,993)
Foreign exchange loss						(17,598)						(440)												(17,158)
Other income, net						11						230												(219)
(Loss) income from operations, before taxes						(16,863)						2,205												(19,068)
Provision for income taxes						(745)						(3,939)												3,194
Net loss						$	(17,608)					$	(1,734)											$	(15,874)

________________________________

1    Cost of revenues excludes depreciation and amortization which are shown separately.

37

Table of Contents

Net revenues decreased $2.7 million to $126.7 million for the nine months ended September 30, 2025, compared to the same period in 2024. The decrease in revenue was mainly attributable to the $3.6 million decrease in professional services and $4.0 million impact of a customer contract that expired in the prior period, partially offset by $3.9 million related to subscriber growth and $1.0 million greater license revenue in the current period.

Cost of revenues decreased $3.3 million to $26.3 million for the nine months ended September 30, 2025, compared to the same period in 2024. The decrease in 2025 was primarily due to lower baseline employee expenses resulting from restructuring measures implemented in the fourth quarter of 2024, as well as cost-saving initiatives aimed at reducing vendor expenditures and overhead.

Research and development expense decreased $1.6 million to $30.9 million for the nine months ended September 30, 2025, compared to the same period in 2024. The decrease in 2025 was primarily attributable to cost-saving initiatives implemented in the fourth quarter of 2024 aimed at streamlining the workforce and reducing vendor expenditures.

Selling, general and administrative expense decreased $4.4 million to $35.4 million for the nine months ended September 30, 2025, compared to the same period in 2024. The decrease in 2025 was primarily attributable to cost-saving initiatives implemented in the fourth quarter of 2024, decrease in facilities expense due to prior year restructuring activity and lower performance-based compensation expense in the current period due to expected full-year metric attainment compared to the prior period performance.

Restructuring charges were $0.2 million and $0.3 million for the nine months ended September 30, 2025 and 2024, respectively, which primarily related to employment termination costs as a result of the work-force reductions initiated to reduce operating costs and align our resources with our key strategic priorities.

Depreciation and amortization expense increased $0.2 million to $12.9 million for the nine months ended September 30, 2025, compared to the same period in 2024. The 2025 increase was primarily attributable to increased amortization of capitalized software due to more amortizable assets placed in service in the current period.

Interest income increased $5.4 million to $5.9 million for the nine months ended September 30, 2025, compared to the same period in 2024. The increase was primarily due to $5.2 million interest income related to the federal tax refund received by the Company during the third quarter of 2025.

Interest expense increased $7.2 million to $19.8 million for the nine months ended September 30, 2025, compared to the same period in 2024. The increase in interest expense is attributable to $4.9 million higher interest on the 2025 Term Loan and $2.3 million higher amortization of deferred financing costs, including $1.7 million amortization of deferred financing costs accelerated due to 2025 Term Loan principal prepayment in the current period.

Debt modification expense was $4.4 million and nil for the nine months ended September 30, 2025 and 2024, respectively, related to deferred financing costs associated with the 2025 Term Loan that were expensed on a pro-rata basis in accordance with debt modification accounting guidance during the current period.

Loss on debt extinguishment was $2.0 million and nil for the nine months ended September 30, 2025 and 2024, respectively, related to pro-rata unamortized debt issuance costs and prepayment premium associated with the 2021 Senior Notes extinguishment during the current period.

Foreign exchange (loss) gain was a loss of $17.6 million compared to a loss of $0.4 million for the nine months ended September 30, 2025 and 2024, respectively, due to the impact of non-cash foreign exchange losses on intercompany payables and receivables primarily between the Company’s U.S. and European entities.

Income tax. The Company recognized income tax expense of approximately $0.7 million and $3.9 million during the nine months ended September 30, 2025 and 2024, respectively. The effective tax rate was approximately (4.4)% for the nine months ended September 30, 2025, which was lower than the U.S. federal statutory rate due to the current period loss from operations before taxes, the impact of permanent adjustments, including Global Intangible Low-Taxed Income, decreased the effective tax rate, while the impact of foreign tax rate differential, and the impact of valuation allowances increased the effective tax rate. In

38

Table of Contents

addition, the Company finalized its 2024 U.S. federal income tax return during the period, which resulted in a discrete tax benefit of $1.7 million primarily attributable to research tax credit and foreign tax credit studies completed prior to filing the tax return. The Company’s effective tax rate was approximately 178.6% for the nine months ended September 30, 2024, which was higher than the U.S. federal statutory rate primarily due to the impact of permanent adjustments, most notably Global Intangible Low-Taxed Income, partially offset by foreign tax rate differential.

Liquidity and Capital Resources

Our principal sources of liquidity have been cash provided by operations. At September 30, 2025 the Company had an aggregate of $34.8 million cash and cash equivalents, and generated operating cash flows of $41.9 million for the nine months ended September 30, 2025. At September 30, 2025, our non-U.S. subsidiaries held approximately $8.0 million of cash and cash equivalents that are available for use by our operations around the world. The Company believes it has sufficient cash and cash equivalents and will generate sufficient liquidity from operations to meet its obligations for at least the next twelve months.

Our policy has been to leave our cumulative unremitted foreign earnings invested indefinitely outside the United States, and we intend to continue this policy for most of our foreign subsidiaries. During 2023, we changed our indefinite reinvestment assertion for our Indian subsidiary and recorded a deferred tax liability associated with the outside basis difference. The Company continues to assert permanent reinvestment of foreign earnings in all other foreign jurisdictions. Due to the timing and circumstances of repatriation of such earnings, if any, it is not practicable to determine the unrecognized deferred tax liability relating to such amounts.

We believe that our cash, cash equivalents, financing sources, and our ability to manage working capital and expected positive cash flows generated from operations in combination with continued expense reductions will be sufficient to fund our operations for the next twelve months from the filing date of this Form 10-Q. However, as the current geopolitical tensions unfold, we will continue to assess any impact on our operations and our liquidity needs. Our liquidity plans are subject to a number of risks and uncertainties, including those described in the "Forward-Looking Statements" section of this MD&A and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, some of which are outside of our control.

Discussion of Cash Flows

A summary of net cash flows follows (in thousands):

			Nine Months Ended September 30,
			2025						2024
Net cash provided by (used in):
Operating activities			$	41,936					$	15,205
Investing activities			(10,183)						(9,109)
Financing activities			$	(30,285)					$	(5,384)

Our primary source of cash is receipts from revenue. The primary uses of cash are personnel and related costs, telecommunications, and facility costs related primarily to our cost of revenue and general operating expenses including professional service fees, consulting fees, building and equipment maintenance and marketing expense.

Cash provided by operating activities for the nine months ended September 30, 2025 was $41.9 million as compared to $15.2 million of cash provided by operating activities for the same period in 2024. In the current period, the Company generated cash from operations mainly driven by continued growth in cloud subscribers and reduced operating costs, $33.9 million federal tax refund (including $5.2 million of accrued interest), offset by $2.5 million higher debt interest paid in 2025, $3.7 million debt issuance and debt extinguishment costs related to modified debt, and favorable movements in working capital in 2025 compared to 2024.

39

Table of Contents

Cash used in investing activities for the nine months ended September 30, 2025 was $10.2 million as compared to $9.1 million of cash used in investing activities during the same period in 2024. The cash used in investing activities during current and prior year primarily funded product development for our Cloud offering and associated labor costs. In 2024, cash used in investing activities was offset by $1.5 million of deferred consideration for the sale of Messaging and NetworkX Businesses received by the company in the third quarter of 2024.

Cash used in financing activities for the nine months ended September 30, 2025 was $30.3 million as compared to $5.4 million of cash used in financing activities during the same period in 2024. The cash used in financing activities in the current year was primarily related to the receipt of $126.4 million proceeds from 2025 Term Loan net of repayment of 2024 Term Loan, offset by $7.9 million in related issuance costs, $121.4 million repayment of 2021 Senior Notes and $0.7 million in related debt extinguishment costs, $25.4 million repayment of 2025 Term Loan principal due to receipt of the federal income tax refund, and $0.8 million of income and payroll taxes paid as a result of stock-based withholding. The cash used in financing activities in the prior year was primarily related to $75.0 million funding of the Term Loan; offset by $6.8 million issuance costs related to the 2024 term loan, $57.6 million Series B Preferred Stock Repurchase, $11.5 million Senior Notes Repurchase and $4.3 million Series B Preferred dividend payments.

Effect of Inflation

Inflationary increases in certain input costs, such as occupancy, labor and benefits, and general administrative costs have impacted our business. Management does not believe these impacts have had a material impact on our results of operations during the three months ended September 30, 2025 and 2024. We cannot assure you, however, that we will not be affected by general inflation in the future.

Contractual Obligations

Our contractual obligations consist of office and laptop leases, notes payable and related interest as well as contractual commitments under third-party hosting, software licenses and maintenance agreements. The following table summarizes our long‑term contractual obligations as of September 30, 2025 (in thousands):

						Payments Due by Period
						Total						2025						2026-2027						2028						Thereafter
Finance lease obligations						$	2,484					$	495					$	1,776					$	213					$	—
Interest						70,007						5,050						40,073						19,341						5,543
Operating lease obligations						16,906						1,812						12,169						2,925						—
Purchase obligations1						33,625						4,275						22,984						6,366						—
2025 Term Loan						174,599						—						—						14,599						$	160,000
Total						$	297,621					$	11,632					$	77,002					$	43,444					$	165,543

_______________________________

1    Amount represents obligations associated with colocation agreements and other customer delivery related purchase obligations.

Uncertain Tax Positions

Unrecognized tax benefits associated with uncertain tax positions were $4.4 million at September 30, 2025. We are not able to reasonably estimate when we would make any cash payments required to settle these liabilities, but we do not believe that the ultimate settlement of our obligations will materially affect our liquidity. The Company anticipates that $3.8 million of its currently unrecognized tax benefits, primarily related to research and development credits and other U.S. tax positions, may be recognized within the next 12 months as a result of a lapse of the statute of limitations.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements in accordance with U.S. GAAP requires us to utilize accounting policies and make certain estimates and assumptions that affect the reported amounts of assets and liabilities,

40

Table of Contents

the disclosure of contingencies as of the date of the financial statements and the reported amounts of revenues and expenses during a fiscal period.

The SEC considers an accounting policy to be critical if it is important to a company’s financial condition and results of operations, and if it requires significant judgment and estimates on the part of management in its application. These estimates and assumptions take into account historical and forward looking factors that the Company believes are reasonable, including but not limited to the potential impacts from current geopolitical tensions. As the extent and duration of the impacts from geopolitical developments remain unclear, the Company’s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from those estimates. If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

The Company’s stock price has experienced a continuous decline during the second and third quarters of 2025. Management monitors the Company’s market capitalization relative to its carrying value as part of its impairment assessment process. While the decline in stock price may indicate potential impairment triggers, management has performed an evaluation of qualitative and quantitative factors and concluded that no impairment charge was required dor the nine months ended September 30, 2025. The Company will continue to monitor its stock price trends and other relevant factors for any potential impact on the recoverability of goodwill or other long-lived assets.

During the nine months ended September 30, 2025, there were no significant changes in our critical accounting policies and estimates from our Annual Report on Form 10-K for the year ended December 31, 2024. Refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024 for a more complete discussion of our critical accounting policies and estimates.

Recently Issued Accounting Standards

For a discussion of recently issued accounting standards see Note 2. Basis of Presentation and Consolidation of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements as of September 30, 2025 and December 31, 2024 that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market Risk

The following discussion about market risk involves forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. We deposit our excess cash in what we believe are high-quality financial instruments, primarily money market funds and certificates of deposit, and we may be exposed to market risks related to changes in interest rates. These investments are denominated in United States dollars.

The primary objective of our investment activities is to preserve our capital for the purpose of funding operations, while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short- and long-term investments in a variety of securities, which could include commercial paper, money market funds and corporate and government debt securities. Our cash and cash equivalents at September 30, 2025 and December 31, 2024 were invested in liquid money market accounts and certificates of deposit. All market-risk sensitive instruments were entered into for non-trading purposes.

41

Table of Contents

Foreign Currency Exchange Risk

We are exposed to translation risk because certain of our foreign operations utilize the local currency as their functional currency and those financial results must be translated into U.S. dollars. As currency exchange rates fluctuate, translation of the financial statements of foreign businesses into U.S. dollars affects the comparability of financial results between years.

We do not hold any derivative instruments and do not engage in any hedging activities. Although our reporting currency is the U.S. dollar, we may conduct business and incur costs in the local currencies of other countries in which we may operate, make sales and buy materials and services. As a result, we are subject to foreign currency transaction risk. Further, changes in exchange rates between foreign currencies and the U.S. dollar could affect our future net sales, cost of sales and expenses, and could result in foreign currency transaction gains or losses.

We cannot accurately predict future exchange rates or the overall impact of future exchange rate fluctuations on our business, results of operations and financial condition. To the extent that our international activities recorded in local currencies increase in the future, our exposure to fluctuations in currency exchange rates will correspondingly increase and hedging activities may be considered if appropriate.

Interest Rate Risk

We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis point movement in interest rates applicable to our cash and cash equivalents outstanding at September 30, 2025 would increase interest income by approximately $0.3 million on an annual basis.

Borrowings pursuant to our 2025 Term Loan Agreement bear interest at a rate per annum equal to secured overnight financing rate, subject to a floor of 2.50%, plus applicable margin of 7.00%. As such, our net income is sensitive to movements in interest rates. If interest rates increase, our debt obligations pursuant to the 2025 Term Loan Agreement would increase even though the amount borrowed remained the same, and our net income would decrease. Such increases in interest rates could have a material adverse effect on our cash flow and financial condition. We do not hold any derivative instruments and do not engage in any hedging activities to mitigate interest rate risk. Based on our outstanding borrowings pursuant to the 2025 Term Loan Agreement as of September 30, 2025 a hypothetical 100 basis point movement in interest rates would have affected interest expense on the debt by $1.8 million on an annual basis.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the registrant’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), as of the end of the period covered by this quarterly report, that ensure that information relating to the registrant which is required to be disclosed in this report is recorded, processed, summarized and reported within required time periods using the criteria for effective internal control established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the registrant’s disclosure controls and procedures were effective as of September 30, 2025.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our controls performed during the three months ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

42

Table of Contents

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

43

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

For a discussion of our material pending legal proceedings that could impact our results of operations, financial condition or cash flows see Note 16. Legal Matters of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.

ITEM 1A. RISK FACTORS

Other than set forth below, there have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 31, 2024.

The terms of our Credit Agreement restrict our operating and financial flexibility, and any breach of the covenants in that agreement, if the lenders elected to accelerate the due date of the loan, could significantly harm our business and prospects and lead to the liquidation of our business.

On June 28, 2024, we entered into a Credit Agreement with BGC Lender Rep LLC, as administrative agent and the lenders party thereto (the “Original Credit Agreement”), which was subsequently amended by that certain First Amendment to Credit Agreement and Pledge and Security Agreement dated April 24, 2025 (the “2025 Term Loan Agreement” and the Original Credit Agreement, as amended by the First Amendment, the “2024 Term Loan Agreement”). The 2025 Term Loan Agreement established a senior secured term loan of up to $200.0 million (the “2025 Term Loan”), all of which was funded on April 24, 2025. The 2025 Term Loan matures on April 24, 2029, subject to an earlier springing maturity date that is nine months prior to the effective date of termination, forfeiture, non-renewal, cancellation, revocation or suspension of certain material contracts if unreplaced in accordance with the terms of the 2025 Term Loan Agreement (the “Springing Maturity Date”). In the event of a Springing Maturity Date, we will be required to pay all amounts outstanding under the 2025 Term Loan sooner than they would otherwise be due. We may not have sufficient funds available to pay such amounts at that time, and we may not be able to raise additional funds to pay such amounts on a timely basis, on terms we find acceptable, or at all.

The 2025 Term Loan Agreement contains certain operating covenants and restricts our operating and financial flexibility. Our obligations under the 2025 Term Loan Agreement are secured by substantially all of our assets (other than existing real property). The 2025 Term Loan Agreement contains customary covenants that limit our ability and our restricted subsidiaries to, among other things, (i) incur additional indebtedness, (ii) pay dividends or make certain other restricted payments, (iii) sell assets, (iv) make certain investments, (v) grant liens and (vi) enter into transactions with affiliates. These covenants are subject to exceptions and qualifications set forth in the 2025 Term Loan Agreement. The financial covenants set forth in the 2025 Term Loan Agreement include (i) a maximum consolidated secured leverage ratio, which will be tested at the end of each of Synchronoss’ fiscal quarters, (ii) a covenant tested monthly with respect to a minimum number of subscribers under certain material contracts and (iii) an average liquidity requirement for any calendar month. As of June 30, 2025, we were currently in compliance with the 2025 Term Loan Agreement covenants, but we may fall out of compliance with these covenants. We may also enter into other debt agreements in the future which may contain similar or more restrictive terms.

Upon the occurrence and continuance of an event of default, which, for example, would be triggered by a breach or violation of, default under, cancellation, termination, forfeiture, rescission, revocation, suspension, impairment or non-renewal of certain material contracts of the Company, BGC may take either or both of the following actions: (i) terminate the commitments and (ii) declare all outstanding obligations immediately due and payable and take such other actions as set forth in the 2025 Term Loan Agreement. Any declaration by BGC of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline significantly. Further, if we were liquidated, the lenders’ rights to repayment would be senior to the rights of our stockholders.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

44

Table of Contents

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans

During the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company “adopted” or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation S-K.

45

Table of Contents

ITEM 6. EXHIBITS

Incorporated by Reference

Exhibit No.

Description

Form

File No.

Exhibit

Filing Date

Filed Herewith

3.1

Restated Certificate of Incorporation of the Registrant.

10-K

001-40574

3.1

March 15, 2023

3.2

Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant.

8-K

001-40574

3.1

June 23, 2022

3.3

Amended and Restated Bylaws of the Registrant.

S-1

333-132080

3.4

May 9, 2006

3.4

Amendment No. 1 to Amended and Restated Bylaws of the Registrant.

8-K

000-52049

3.2

February 20, 2018

3.5

Amendment No. 2 to the Amended and Restated Bylaws of the Registrant.

8-K

000-52049

3.3

June 30, 2021

3.6

Certificate of Designations of the Series B Perpetual Non-Convertible Preferred Stock.

8-K

000-52049

3.1

June 30, 2021

3.7

Certificate of Amendment of the Restated Certificate of Incorporation of Synchronoss Technologies, Inc.

8-K

001-40574

3.1

December 7, 2023

3.8

Certificate of Elimination of the Series B Perpetual Non-Convertible Preferred Stock.

8-K

001-40574

3.1

July 1, 2024

10.1

Synchronoss Technologies, Inc. Amended and Restated 2015 Equity Incentive Plan.

10-Q

001-40574

10.1

November 12, 2024

31.1

Certification of Principal Executive Officer pursuant to Rule 13a‑14(a) of the Exchange Act, as adopted pursuant to section 302 of the Sarbanes‑Oxley Act of 2002.

X

31.2

Certification of Principal Financial Officer pursuant to Rule 13a‑14(a) of the Exchange Act, as adopted pursuant to section 302 of the Sarbanes‑Oxley Act of 2002.

X

32.1

Certification of Principal Executive Officer pursuant to Rule 13a‑14(b) of the Exchange Act and section 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes‑Oxley Act of 2002.

X

32.2

Certification of Principal Financial Officer pursuant to Rule 13a‑14(b) of the Exchange Act and section 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes‑Oxley Act of 2002.

X

101.INS

XBRL Instance Document

X

101.SCH

XBRL Schema Document

X

101.CAL

XBRL Calculation Linkbase Document

X

101.DEF

XBRL Taxonomy Extension Definition Linkbase

X

101.LAB

XBRL Labels Linkbase Document

X

101.PRE

XBRL Presentation Linkbase Document

X

46

Table of Contents

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Synchronoss Technologies, Inc.

/s/ Jeff Miller

Jeff Miller

Chief Executive Officer

(Principal Executive Officer)

/s/ Louis Ferraro

Louis Ferraro

Chief Financial Officer

November 4, 2025

47

FAQ

What were SNCR’s Q3 2025 revenues and earnings?

Q3 net revenues were $42,003 thousand with net income of $5,813 thousand (diluted EPS $0.51).

How did cash flow and liquidity look for SNCR in Q3 2025?

Net cash from operating activities was $41,936 thousand, and cash and equivalents were $34,827 thousand.

What is the status of Synchronoss’s debt after Q3 2025?

Long‑term debt carrying value was $163,200 thousand. A $25.4 million prepayment from a CARES Act refund reduced near‑term principal requirements.

Which service lines drove SNCR’s Q3 revenue?

Subscription Services led with $39,389 thousand, followed by Professional Services at $2,614 thousand.

What regions contributed most to SNCR’s Q3 2025 revenue?

North America generated $40,430 thousand, APAC $1,236 thousand, and EMEA $337 thousand.

How did equity change during 2025 for SNCR?

Stockholders’ equity increased to $55,354 thousand, aided by comprehensive income and elimination of a $12,500 thousand redeemable non‑controlling interest.

How many SNCR shares were outstanding recently?

As of November 3, 2025, there were 11,507,434 common shares outstanding.